WO1998026808A2 - Articles absorbants dotes d'un systeme de suppression des mauvaises odeurs - Google Patents

Articles absorbants dotes d'un systeme de suppression des mauvaises odeurs Download PDF

Info

Publication number
WO1998026808A2
WO1998026808A2 PCT/US1997/022576 US9722576W WO9826808A2 WO 1998026808 A2 WO1998026808 A2 WO 1998026808A2 US 9722576 W US9722576 W US 9722576W WO 9826808 A2 WO9826808 A2 WO 9826808A2
Authority
WO
WIPO (PCT)
Prior art keywords
odor
cyclodextrin
perfume
absorbent
mixtures
Prior art date
Application number
PCT/US1997/022576
Other languages
English (en)
Other versions
WO1998026808A3 (fr
Inventor
Toan Trinh
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to EP97952337A priority Critical patent/EP0946209A2/fr
Priority to CA002275302A priority patent/CA2275302A1/fr
Priority to AU55972/98A priority patent/AU739247B2/en
Priority to MX9905739A priority patent/MX9905739A/es
Priority to KR19997005447A priority patent/KR20000069529A/ko
Priority to JP10527792A priority patent/JP2000505692A/ja
Publication of WO1998026808A2 publication Critical patent/WO1998026808A2/fr
Publication of WO1998026808A3 publication Critical patent/WO1998026808A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/42—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators with wetness indicator or alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/108—Elemental carbon, e.g. charcoal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/622—Microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Definitions

  • the present invention relates to an improvement in absorbent articles such as catamenials, diapers, and adult incontinence garments, with a system for malodor control and, optionally, a means to provide a "scent signal" in the form of a pleasant odor which signals the removal of odor during use of the product.
  • the odor-absorbing system herein is designed to combat a broad spectrum of odoriferous materials, including sour "ammonia-type" odors.
  • fluid absorbent structures known in the art absorb body fluids such as blood, urine, menses, and the like, and are sanitary and comfortable in use.
  • Disposable products of this type generally comprise fluid-permeable topsheet material, fluid absorbent core, and fluid-impermeable backsheet material.
  • Various shapes, sizes and thicknesses of such articles have been explored in an attempt to make their use more comfortable and convenient.
  • Odor control in sanitary products has been under investigation for many years. Many body fluids have an unpleasant odor, or develop such odors when in contact with air and/or bacteria for prolonged periods.
  • ABSCENTS odor-control molecular sieve from Union Carbide
  • U.S. Pat. Nos. 4,795,482 and 4,826,497 relate to ABSCENTS used as an odor-controlling material, generally, and in sanitary products, in particular.
  • Zeolitic materials are generally quite safe, and while they do effectively control many odors associated with body fluids, unfortunately, they do not provide optimal control for ammonia odor and similar odors, presumably associated with short-chain amines and/or urea.
  • SiO2:AlO2 so-called “high ratio” (SiO2:AlO2) odor-controlling zeolites.
  • Certain “intermediate ratio” (SiO2:AlO2) zeolites are more effective for adsorbing amine-type odors.
  • a "scent signal” is a positive perfume odor which signals the removal of odor during use of the product. This scent signal is normally difficult to provide because odor absorbents can react with and/or deplete the perfume in the article prior to use, and the absorbents themselves can become inactive.
  • the present invention provides an improvement to the art by incorporating odor- absorbing materials for malodor control and materials that are antibacterials and/or urease inhibitors to minimize the formation of such odors.
  • the combination of these two approaches in an odor control system has been found to be the most effective way to combat odor.
  • the compositions and articles herein can also contain moisture- activated encapsulated perfumes for an in-use "burst of fragrance” or "scent signal,” into absorbent compositions and articles of manufacture.
  • the present invention relates to absorbent compositions which minimize the odor that can be caused by bodily fluids and which optionally, but preferably, provide a scent signal indicating that the odor is being removed, comprising:
  • odor-absorbing material for objectionable odor molecules, said odor absorbing material preferably being selected from the group consisting of:
  • the present invention also relates to consumer articles of manufacture containing the above compositions, such as diapers, catamenials, pantiliners, adult incontinence garments, and underarm shields, which decrease odors associated with bodily fluids such as blood, urine, and the like, and which provide a pleasant scent signal.
  • consumer articles of manufacture containing the above compositions, such as diapers, catamenials, pantiliners, adult incontinence garments, and underarm shields, which decrease odors associated with bodily fluids such as blood, urine, and the like, and which provide a pleasant scent signal.
  • compositions and methods for odor control involve the use of odor-controlling and odor-absorbing material, as described more fully hereinafter.
  • compositions of odor-controlling and odor- absorbent materials and moisture-activated encapsulated perfumes can be prepared using constituents that are well-known in current commercial practice.
  • Such items typically comprise a moisture absorbent "core” (e.g., pad) interposed between a "topsheet” and a “backsheet.”
  • core e.g., pad
  • the various individual constituents used in the assembly of catamenials, disposable diapers, and the like, are well-known.
  • the present invention relates to the novel combination of odor-controlling materials and odor-absorbent materials as constituents of such articles.
  • the absorbent compositions contains an effective amount of urease inhibitor and/or antimicrobials.
  • Metallic Salts are an effective amount of urease inhibitor and/or antimicrobials.
  • the absorbent compositions products of the present invention are prepared by contacting the solid absorbent compositions material with, preferably, an aqueous solution of the antimicrobial and/or urease inhibitor, preferably transition metal ion.
  • the antimicrobial and/or urease inhibitor preferably transition metal ion.
  • Suitable sources of the transition metal ions are their soluble salts.
  • the preferred salts are silver, copper, zinc, ferric, and aluminum salts, more preferably zinc. It is also desirable that the anion provide some benefit. E.g., the anion can have the ability to provide urease inhibition, such as borate, phytate, etc.
  • Suitable examples are silver chlorate, silver nitrate, mercury acetate, mercury chloride, mercury nitrate, copper metaborate, copper bromate, copper bromide, copper chloride, copper dichromate, copper nitrate, copper salicylate, copper sulfate, zinc acetate, zinc borate, zinc phytate, zinc bromate, zinc bromide, zinc chlorate, zinc chloride, zinc sulfate, cadmium acetate, cadmium borate, cadmium bromide, cadmium chlorate, cadmium chloride, cadmium formate, cadmium iodate, cadmium iodide, cadmium permanganate, cadmium nitrate, cadmium sulfate, and gold chloride.
  • Other salts that have been disclosed as having urease inhibition properties include ferric and aluminum salts, especially the nitrates, and bismuth salts. Zinc salts are preferred.
  • the preferred, metallic salt preferably water-soluble zinc salts
  • a water-soluble metallic salt can be used as an odor control material.
  • a water-soluble metallic salt can be present in the freshening composition of the present invention to absorb amine and sulfur-containing compounds. Furthermore, they usually do not contribute an odor of their own.
  • the water-soluble metallic salts are selected from the group consisting of copper salts, zinc salts, and mixtures thereof.
  • the preferred zinc salts have been used most often for their ability to ameliorate malodor, e.g., in mouth wash products, as disclosed in U.S. Pat. Nos. 4,325,939, issued Apr. 20, 1982 and 4,469,674, issued Sept. 4, 1983, to N. B. Shah, et al., incorporated herein by reference.
  • U.S. Pat. No. 3,172,817, issued to Leupold, et al. discloses deodorizing compositions containing slightly water-soluble salts of an acyl-acetone with a polyvalent metal, including copper and zinc salts. Said patents are incorporated herein by reference.
  • Examples of preferred water-soluble zinc salts are zinc chloride, zinc gluconate, zinc lactate, zinc maleate, zinc salicylate, zinc sulfate, etc. Highly-ionized and soluble zinc salts such as zinc chloride, provide the best source of zinc ions.
  • Examples of preferred copper salts are copper chloride and copper gluconate.
  • Preferred metallic salts are zinc chloride and copper chloride.
  • Metallic salts are added to the absorbent composition of the present invention typically at a level of from about 0.001% to about 1%, preferably from about 0.002% to about 0.7%, more preferably from about 0.03% to about 0.5%, by weight of the absorbent compositions.
  • Urease Inhibitors are added to the absorbent composition of the present invention typically at a level of from about 0.001% to about 1%, preferably from about 0.002% to about 0.7%, more preferably from about 0.03% to about 0.5%, by weight of the absorbent compositions.
  • a partial list of materials that exhibit urease inhibition and/or suppression includes the metallic salts listed above; hydroxamic acid, modified hydroxamic and/or dihydroxyamic acids, e.g., substituted with various hydrocarbon groups such as acyl, e.g., aceto-, chloronitrobenzamidoaceto-, and nitrobenzamidoaceto- (e.g., 2-para), Cj_2i alkyl, aryl, and/or alkaryl groups, cycloalkyl (e.g., cyclohexyl), peptidyl, naphthyloxy-alkane, and their salts; thiourea; hydroxylamine; salts of phytic acid, especially sodium, potassium, calcium, and magnesium; extracts of plants of various species, including various tannins, e.g.
  • carob tannin and their derivatives such as chlorogenic acid derivatives; naturally occurring acids such as ascorbic acid, citric acid, and their salts; phenyl phosphoro diamidate/diamino phosphoric acid phenyl ester; metal aryl phosphoramidate complexes, including substituted phosphorodiamidate compounds; phosphoramidates without substitution on the nitrogen; boric acid and/or its salts, including especially, borax, and/or organic boron acid compounds; the compounds disclosed in European Patent Application 408,199, incorporated by reference; sodium, copper, manganese, and/or zinc dithiocarbamate; quinones; phenols; thiurams; substituted rhodanine acetic acids; alkylated benzoquinones; formamidine disulphide; 1 :3-diketones maleic anhydride; succinamide; phthalic anhydride; pehenic acid; /N,N-dihalo-2-imidazolidinones; N
  • urease inhibitors are known, some having been purposefully synthesized by the pharmaceutical industry, and others whose original use was for purposes outside the realm of urease inhibition, but which can also be suitably employed to act as structural mimics of urea.
  • These latter compounds include low molecular weight, water soluble materials which act as an irreversible substrate or modifier of the active site of the urease enzyme.
  • hydroxamic acid hydroxamic acid and the substituted hydroxamic acids mentioned above.
  • Acetohydroxamic and propionhydroxamic acid are the most common of the acyl substituted hydroxamic acids. These two compounds, as well as the parent hydroxamic acid and the alkali or alkaline earth salts of said acids, are particularly efficacious in inhibiting urease enzyme activity in vitro.
  • a variety of phosphorus compounds including those disclosed hereinbefore, have been prepared for in vivo reduction in urease activity. Many of the pharmaceutical industry generated products are compatible with the environment due to their bio- degradability and the structure and oxidation state of the phosphorus containing moiety.
  • R is hydrogen, phenyl, substituted phenyl, alkyl, alkenyl, and other suitable moieties or preferably N-(diaminophosphinyl)arylcarboxamides of the formula:
  • R*, R ⁇ , R3, and R4 is more preferably hydrogen, nitro, halogen, amino, Ci _4 alkyl, Cj_4 alkoxy, trifluormethyl, cyano, phenoxy, phenyl, and mixtures thereof.
  • a further embodiment of the present invention includes urease inhibitors of the general formula:
  • R* and R ⁇ are the same or different and are hydrogen or alkyl having from 1 to about 4 carbon atoms;
  • R3 is oxygen or sulfur
  • a variety of nitrogen containing compounds have been prepared for in vivo use against
  • Ri is aryl
  • it is preferably selected from substituted and unsubstituted, preferably 2-furanyl, 3-furanyl, 2-thienyl, 2-pyrrolyl, 3-pyrrolyl and phenyl.
  • R* is alkyl, it is preferably selected from substituted and unsubstituted, preferably unsubstituted C ⁇ - Ci g alkyl,
  • R2 is aryl, it is preferably selected from substituted and unsubstituted, preferably 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-pyrrolyl and phenyl.
  • R2 is alkyl, it is preferably selected from substituted and unsubstituted, preferably unsubstituted Ci -Cjg alkyl, more preferably Cj-Ci 2 straight chain.
  • R3 When R3 is aryl, it is preferably substituted or unsubstituted phenyl.
  • R ⁇ is alkyl, it is preferably selected from substituted and unsubstituted, preferably unsubstituted C ⁇ -C ⁇ g alkyl, more preferably C1 -C12 straight chain. R ⁇ is most preferably hydrogen.
  • R4 When R4 is aryl, it is preferably substituted or unsubstituted phenyl.
  • R ⁇ When R ⁇ is alkyl, it is preferably selected from substituted and unsubstituted, preferably unsubstituted C ⁇ -C ⁇ g alkyl, more preferably C1-C12 straight chain.
  • R4 is most preferably hydrogen.
  • R6 is aryl, it is preferably substituted or unsubstituted phenyl.
  • R ⁇ is alkyl, it is preferably selected from substituted and unsubstituted, preferably unsubstituted Ci -Cjg alkyl, more preferably C1-C12 straight chain. R ⁇ is most preferably hydrogen.
  • Suitable compounds for use in the present invention include syn- and anti-forms or mixtures thereof.
  • R ⁇ R2 wherein R is hydrogen; or R and R ⁇ are the same or different C 1 -C22 alkyl and branched alkyl, C1-C22 alkenyl or branched alkenyl; an aryl group substituted with one or more amino; heterocyclic rings, preferably 2-furanyl, substituted 2-furanyl, 3-furanyl, and substituted 3-furanyl wherein the furanyl substituents are one or more alkyl, amino, cyano, nitro, alkylamino, dialkylamino, aryl mercapto, isocyanato, trihalomethyl, alkoxy, thiocyano, alkanoyl and halogen moieties; in the case where two aryl or two heterocyclic rings or one of each are present that contain more than one substituent, for example, when R or R ⁇ each comprise an aryl or heterocyclic ring such as a 2,4-dichlorofuranyl, 2-chloro-4-methylfuranyl,
  • R is hydrogen; or R and R ⁇ are the same or different C1-C22 alkyl and branched alkyl, C1-C22 alkenyl or branched alkenyl; aryl groups substituted by one or more halogen, hydroxy, mercapto, alkyl mercapto, O-diaminophosphinyl, S- diaminophosphinyl, diaminophosphinyl.
  • R and R ⁇ taken together may form an alkylene or alkenylene chain which may optionally include one of more divalent oxygen, nitrogen, or sulfur moieties forming a 3, 4, 5 or six membered fused ring structure;
  • R and R ⁇ each comprise a heterocyclic ring, preferably 2-furanyl, substituted 2-furanyl, 3-furanyl, and substituted 3-furanyl; are efficacious as urease inhibitors when added in an amount sufficient to inhibit the enzyme urease.
  • the furanyl substituents can be substituted by one or more alkyl, amino, cyano, nitro, alkylamino, dialkylamino, aryl mercapto, isocyanato, trihalomethyl, alkoxy, thiocyano, alkanoyl and halogen moieties and mixtures thereof.
  • R or R ⁇ may each comprise the same or different di-substituted aryl or heterocyclic moiety such as 2,4-dichlorofuranyl, 2-chloro-4-methylfuranyl, or a tri-substituted moiety such as 2,4,6-trichlorophenyl, or 3, 4,5-trichloro uranyl.
  • violuric acid and derivatives of violuric acid having the general formula:
  • R and R ⁇ can be the same or different and are hydrogen, C1 -C22 alkyl and branched alkyl, C1 -C22 alkenyl or branched alkenyl; an aryl or heterocyclic ring substituted by one or more amino, halogen, hydroxy, mercapto, alkyl mercapto, O- diaminophosphinyl, S-diaminophosphinyl, diaminophosphinyl, diaminophosphonyl, cyano, nitro, alkylamino, dialkylamino, aryl mercapto, isocyanato, trihalomethyl, alkoxy, thiocyano, alkanoyl or mixtures thereof.
  • the urease inhibitor is included in the absorbent composition of the present invention in an effective amount to provide an odor improvement.
  • effective amount means a level sufficient to inhibit, or significantly reduce the hydrolysis of urea for a specific amount of time that is related to the expected time that the article will exist with urea present. Such a time is at least about 2 hours, and preferably the effect should be noticeable at longer times, e.g., overnight, or even several days, if the article is stored until final disposal can take place.
  • Preferred levels of urease inhibitor are from about 0.0002% to about 2%, preferably from about 0.002% to about 0.5%, and most preferably from about 0.01% to about 0.3%, by weight of the composition.
  • Organic antimicrobials can also be used in the present invention. It is preferable to use a broad spectrum antimicrobial, e.g., one that is effective on both bacteria (both gram positive and gram negative) and fungi.
  • a limited spectrum antimicrobial e.g., one that is only effective on a single group of microorganisms, e.g., fungi, can be used in combination with a broad spectrum antimicrobial or other limited spectrum antimicrobials with complimentary and/or supplementary activity.
  • a mixture of broad spectrum antimicrobials can also be used.
  • Antimicrobial antimicrobials useful in the present invention can be biocidal compounds, i.e., substances that kill microorganisms, or biostatic compounds, i.e., substances that inhibit and/or regulate the growth of microorganisms.
  • Preferred antimicrobial antimicrobials are those that are water-soluble and are effective at low levels because the organic antimicrobials can form inclusion complexes with the preferred cyclodextrin molecules in the treatment solution used to form the animal litter, thus rendering the complexed antimicrobials much less effective.
  • Water- soluble antimicrobials useful in the present invention are those that have a solubility in water of at least about 0.3 g per 100 ml of water, i.e., about 0.3% at room temperature, preferably greater than about 0.5% at room temperature. These types of antimicrobials have a lower affinity to the cyclodextrin cavity, at least in the aqueous phase, and are therefore more available to provide antimicrobial activity.
  • antimicrobials such as short chain alkyl esters of p-hydroxybenzoic acid, commonly known as parabens; N- (4-chlorophenyl)-N'-(3,4-dichlorophenyl) urea, also known as 3,4,4'-trichlorocarbanilide or triclocarban; 2,4,4'-trichloro-2'-hydroxy diphenyl ether, commonly known as triclosan are not preferred in the present invention since they are relatively ineffective when used in conjunction with cyclodextrin.
  • the water-soluble antimicrobial is included in the absorbent composition of the present invention in an effective amount.
  • effective amount means a level sufficient to significantly inhibit, or prevent growth of microorganisms for a specific period of time, as discussed above.
  • Preferred levels of antimicrobial are from about 0.0005% to about 0.5%, more preferably from about 0.001% to about 0.3%, most preferably from about 0.003% to about 0.1 %, by weight of the composition.
  • the antimicrobial can be any organic antimicrobial material.
  • Alkyl monocarboxylic acids having from about 3 to about 9 carbon atoms and halogenated aromatic hydrocarbons, e.g., halogenated phenols, halogenated diphenyls and halogenated bis-phenols such as para-chloro-meta-cresol, hexachlrophene, 2,4,4'- trichloro-2'-hydroxydiphenyl ether, trichlorocarbanalide, 2.4-dichloro-meta-xylenol, 3,4,5-tribromosalicylanalide, 3,5,3',4'-tetrachlorosalicylanalide, and mixtures thereof, can be used.
  • Preferred water-soluble antimicrobials include organic sulfur compounds, halogenated compounds, cyclic organic nitrogen compounds, low molecular weight aldehydes, quaternary compounds, dehydroacetic acid, phenyl and phenoxy compounds, and mixtures thereof.
  • Non-limiting examples of the preferred water-soluble antimicrobials for use in the present invention include a mixture of about 77% 5-chloro-2-methyl-4-isothiazolin-3- one and about 23% 2-methyl-4-isothiazolin-3-one, a broad spectrum antimicrobial available as a 1.5% aqueous solution under the trade name Kathon® CG by Rohm and Haas Co.; 5-bromo-5-nitro-l,3-dioxane, available under the trade name Bronidox L® from Henkel; 2-bromo-2-nitropropane-l,3-diol, available under the trade name Bronopol ® from Inolex; l,l'-hexamethylene bis(5-(p-chlorophenyl)biguanide), commonly known as chlorhexidine, and its salts, e.g., with acetic and digluconic acids; a 95:5 mixture of 1 ,3-bis(hydroxymethyl)-5,5-dimethyl
  • compositions and articles of this invention contain an effective, i.e., odor- absorbing, amount of various odor-absorbing materials.
  • Such materials include, for example, cyclodextrins, zeolites, activated carbon, kieselguhr, chelating agents, chitin, pH buffered materials, and the like.
  • cyclodextrins especially beta-cyclodextrin, and zeolite material having "intermediate" silicate/aluminate ratios (vide infra).
  • Some partially neutralized hydrogel-forming absorbent gelling materials such as polyacrylate gelling material and acrylate grafted starch gelling material (vide infra), are also useful in the present invention to control certain ammonia-type odors. These materials are discussed with IV. Fluid Absorbent Material because they also function as fluid absorbent materials. (A). Cyclodextrins
  • the preferred odor absorbing material is uncomplexed cyclodextrin which can be added to the composition of the present invention.
  • cyclodextrin includes any of the known cyclodextrins such as unsubstituted cyclodextrins containing from six to twelve glucose units, especially, alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin and/or their derivatives and/or mixtures thereof.
  • the alpha-cyclodextrin consists of six glucose units, the beta-cyclodextrin consists of seven glucose units, and the gamma-cyclodextrin consists of eight glucose units arranged in a donut-shaped ring.
  • the specific coupling and conformation of the glucose units give the cyclodextrins a rigid, conical molecular structure with a hollow interior of a specific volume.
  • the "lining" of the internal cavity is formed by hydrogen atoms and glycosidic bridging oxygen atoms, therefore this surface is fairly hydrophobic.
  • the unique shape and physical-chemical property of the cavity enable the cyclodextrin molecules to absorb (form inclusion complexes with) organic molecules or parts of organic molecules which can fit into the cavity. Many odor molecules can fit into the cavity.
  • Non-derivatised (normal) beta-cyclodextrin can be used and is preferred.
  • the aqueous solution is preferably heated.
  • a preferred method is to spray an almost saturated aqueous solution of beta-cyclodextrin, preferably heated, e.g., from about 40°C to about 90°C, preferably from about 50°C to about 80°C, more preferably from about 60°C to about 75°C, onto the absorbent material, preferably with mixing or stirring, to permit a uniform incorporation of as much as possible of the cyclodextrin with the least amount of water.
  • beta-cyclodextrin powder in the slurry typically has an average particle size of less than about 12 microns, preferably less than about 10 microns, more preferably less than about 8 microns, and even more preferably less than about 5 microns, to provide the best odor control benefit.
  • the particle size is typically between about 0.001 and 10 microns, preferably between about 0.05 and 5 microns. It is highly desirable that at least an effective amount of particles having the said particle sizes. It is desirable that at least about 50%), preferably at least about 65%, more preferably at least about 80%, of the beta-cyclodextrin powder that is present have the said particle sizes.
  • small particles of the invention are conveniently prepared by grinding techniques.
  • Cyclodextrin crystals with large particle sizes can be pulverized to obtain the desired smaller particles of less than about 12 microns by using, e.g., a fluid energy mill.
  • the large beta-cyclodextrin crystals can be pulverized into small particles, then added to water to form the desired slurry.
  • a slurry of large beta-cyclodextrin can be milled to obtain a small particle size slurry.
  • fluid energy mills examples include the Trost Air Impact Pulverizers, sold by Garlock Inc., Plastomer Products, Newtown, Pennsylvania; the Micronizer fluid energy mills sold by Sturtevant, Inc., Boston, Massachusetts; and the Spiral Jet Mill sold by Alpine Division, MicroPul Corporation (Hosokawa Micron International, Inc.), Summit, New Jersey.
  • the particle size refers to the largest dimension of the particle and to the ultimate (or primary) particles.
  • the size of these primary particles can be directly determined with optical or scanning electron microscopes. The slides must be carefully prepared so that each contains a representative sample of the bulk cyclodextrin powder.
  • the particles sizes can also be measured by any of the other well-known methods, e.g., wet sieving (non-aqueous), sedimentation, light scattering, etc.
  • a convenient instrument that can be used to determine the particle size distribution of the dry powder directly (without having to make a liquid suspension or dispersion) is the Malvern Particle and Droplet Sizer, Model 2600C, sold by Malvern Instruments, Inc., Southborough, Massachusetts.
  • cyclodextrins useful in the present invention are highly water-soluble such as, alpha-cyclodextrin and derivatives thereof, gamma-cyclodextrin and derivatives thereof, derivatised beta-cyclodextrins, and/or mixtures thereof.
  • the derivatives of cyclodextrin consist mainly of molecules wherein some of the OH groups are converted to OR groups.
  • Cyclodextrin derivatives include, e.g., those with short chain alkyl groups such as methylated cyclodextrins, and ethylated cyclodextrins, wherein R is a methyl or an ethyl group; those with hydroxyalkyl substituted groups, such as hydroxypropyl cyclodextrins and/or hydroxyethyl cyclodextrins, wherein R is a "CH2-CH(OH)-CH3 or a "CH2CH2-OH group; branched cyclodextrins such as maltose-bonded cyclodextrins; cationic cyclodextrins such as those containing 2-hydroxy-3(dimethylamino)propyl ether, wherein R is CH2-CH(OH)-CH2-N(CH3)2 which is cationic at low pH; quaternary ammonium, e.g., 2-hydroxy-3-(trimethylammonio
  • Highly water : soluble cyclodextrins are those having water solubility of at least about 10 g in 100 ml of water at room temperature, preferably at least about 20 g in 100 ml of water, more preferably at least about 25 g in 100 ml of water at room temperature. These are easy to use, but are typically more expensive than the non-derivatized beta- cyclodextrin.
  • Examples of preferred water-soluble cyclodextrin derivatives suitable for use herein are hydroxypropyl alpha-cyclodextrin, methylated alpha-cyclodextrin, methylated beta-cyclodextrin, hydroxyethyl beta-cyclodextrin, and hydroxypropyl beta- cyclodextrin.
  • Hydroxyalkyl cyclodextrin derivatives preferably have a degree of substitution of from about 1 to about 14, more preferably from about 1.5 to about 7, wherein the total number of OR groups per cyclodextrin is defined as the degree of substitution.
  • Methylated cyclodextrin derivatives typically have a degree of substitution of from about 1 to about 18, preferably from about 3 to about 16.
  • a known methylated beta-cyclodextrin is heptakis-2,6-di-O-methyl- ⁇ -cyclodextrin, commonly known as DIMEB, in which each glucose unit has about 2 methyl groups with a degree of substitution of about 14.
  • a preferred, more commercially available methylated beta- cyclodextrin is a randomly methylated beta-cyclodextrin having a degree of substitution of about 12.6.
  • the preferred cyclodextrins are available, e.g., from Cerestar USA, Inc. and Wacker Chemicals (USA), Inc.
  • cyclodextrins can complex with a wider range of odor molecules having a wider range of molecular sizes.
  • Preferably at least a portion of such a mixture of cyclodextrins is alpha-cyclodextrin or its derivatives, gamma-cyclodextrin or its derivatives thereof, and/or beta-cyclodextrin or its derivatives.
  • Cyclodextrin molecules are known for their ability to form complexes with perfume ingredients and have typically been taught as a perfume carrier.
  • the prior art teaches the use of drier-added fabric softener sheets containing high levels of cyclodextrin/perfume complexes wherein the fabrics treated with this solid cyclodextrin complex release perfume when the fabrics are rewetted.
  • the art also teaches that cyclodextrin/perfume complexes used in aqueous rinse-added fabric softener compositions must be protected, e.g., with a hydrophobic wax coating so the cyclodextrin/perfume complexes will not decompose due to the presence of water. See U.S. Pat.
  • the cyclodextrin is preferably applied as a spray. It is preferable that the level of cyclodextrin is from about 0.01% to about 30%, preferably from about 0.01% to about 25%), more preferably from about 0.5% to about 20%, most preferably from about 1% to about 15%, by weight of the absorbent composition. Absorbent compositions with higher concentrations are more effective, but are not normally economical.
  • the absorbent article of the present invention typically contains from about 0.01 g to about 20 g, preferably from about 0.02 g to about 15 g and more preferably from about 0.03 g to about 10 g, of uncomplexed cyclodextrin.
  • B Zeolite Odor- Absorbing Material
  • zeolites comprise an aluminate/ silicate framework, with associated cations, M, providing overall electrical neutrality.
  • the zeolite framework can be represented as x AIO2 • y SiO and the electrically neutral zeolite as x/n M . x AlO 2 . y Si ⁇ 2 . z H2O wherein: x and y are each integers, M is a cation and n is the charge on the cation.
  • zeolites may also comprise waters of hydration (z H2O).
  • M can be a wide variety of cations, e.g., Na + , K + , NH_ ⁇ + , alkylammonium, heavy metals, and the like.
  • a preferred class of zeolites useful in the present invention is characterized as "intermediate" silicate/aluminate zeolites.
  • the "intermediate” zeolites are characterized by SiO2 AlO2 molar ratios of less than about 10. Typically, the molar ratio of SiO2 AlO2 will range from about 2 to about 10.
  • the intermediate zeolites have three advantages over "high" zeolites, disclosed in U.S. Pat. Nos. 4,795,482 and 4,826,497, which are incorporated herein by reference. First, the intermediate zeolites have a higher capacity for amine-type odors which is important for absorbing urine and menses odors.
  • the intermediate zeolites have a larger surface area (about 700-800 m ⁇ /g) than high zeolites (about 400 m ⁇ /g). Therefore, less intermediate zeolite is needed to absorb a given amount of odor on a weight to weight basis. Third, intermediate zeolites are more moisture tolerant and retain more odor-absorbing capacity in the presence of water.
  • zeolites suitable for use herein are commercially available as VALFOR CP301-68, VALFOR 300-63, VALFOR CP300-35 and VALFOR CP300-56, from PQ Corporation, and the CBV100 series (other than Mordenite, as noted below) of zeolites from Conteka.
  • zeolites used herein are not of the fibrous type, e.g., various Mordenites, and some types of Y zeolites, since these may be subject to safety issues. Accordingly, the term "zeolite" as used herein is intended to encompass only the nonfibrous zeolites. While some naturally-occurring zeolites meet the objectives of this invention, the synthetic zeolites of the types available in commerce are generally more preferred.
  • High zeolites are also preferred and can be employed in the practice of this invention either alone, or in combination with the intermediate ratio zeolites.
  • High zeolites include, for example, the well-known "molecular sieve" zeolites of the ZSM, beta zeolite, etc., type (generally in the 1-10 micron particle size range) and the zeolite materials marketed under the trade name ABSCENTS by the Union Carbide Corporation and UOP.
  • ABSCENTS are typically available as a white powder in the 3-5 micron particle size range (See: ABSCENTS, A New Approach for Odor Control by A. J. Gioffre, copyright 1988 by the Union Carbide Corporation).
  • Such materials are preferred over the "intermediate" zeolites for control of odors associated with sulfur compounds, e.g., thiols, mercaptans.
  • modified zeolite-type materials which can be used in the present invention, such as the manganese-aluminum-phosphorus-silicon-oxide molecular sieves and other zeolite odor-absorbing compositions are described in U.S. Pat. Nos. 4,793,833, Lok et al.; 4,604,110; 4,437,429; and 4,648,977, which are incorporated herein by reference.
  • the absorbent article of the present invention typically contains from about 0.01 g to about 20 g, preferably from about 0.02 g to about 15 g and more preferably from about 0.01 g to about 10 g, of zeolite. (C). Carbon Odor-Absorbing Material
  • the carbon material employed herein is the material well known in commercial practice as an adsorbent for organic molecules and/or for air purification purposes. Carbon suitable for use herein is available from a variety of commercial sources under trade names such as CALGON Type “CPG”, Type “PCB”, Type “SGL”, Type “CAL”, and Type “OL.” Often, such carbon material is referred to simply as “activated” carbon or “activated” charcoal. Typically, it is available in the form of extremely fine, dusty particles (e.g., 0.1-300 microns) having large surface areas (about 200 to several thousand nvVg). It is to be understood that any of the "air purifying” or “activated” carbons of commerce can be used in the practice of this invention.
  • the zeolites herein are optionally used in conjunction with the activated carbon, it is preferred (for aesthetics reasons) to coat the carbon with the zeolite using a binder.
  • Moisture-activated encapsulated perfume includes any encapsulated perfume system which will release the perfume when wetted by water.
  • moisture- activated perfume includes cyclodextrin/perfume inclusion complexes, polysaccharide matrix perfume microcapsules, and mixtures thereof.
  • the odor absorbing material and the moisture-activated encapsulated perfume can be present in the fluid-retaining absorbent core or the fluid-receiving front face (topsheet) of these articles.
  • Cyclodextrin/perfume inclusion complexes are very stable in the dry state. Even the very volatile perfume molecules are bound in the cavity of the cyclodextrin molecules and do not provide perceptible odor. Upon wetting by an aqueous fluid such as a body fluid, the perfume is released to provide a burst of fragrance. A greater variety of perfumes can be used to accommodate a variety of consumer preferences.
  • the perfume is dispersed as minute droplets in, e.g., a starch/dextrin solid cellular matrix. Moisture swells and softens the polysaccharide matrix to release the encapsulated per ume.
  • cyclodextrin/perfume inclusion complexes and the polysaccharide matrix perfume microcapsules contain volatile perfume.
  • compositions and articles of this invention preferably contain an effective amount of various moisture-activated encapsulated perfume particles.
  • Such materials include, for example, cyclodextrin/perfume inclusion complexes, polysaccharide cellular matrix perfume microcapsules, and the like. Encapsulation of perfume minimizes interaction with, and/or depletion by, odor-absorbing materials before use of the product. Perfume is released when the materials are wetted, to provide a pleasant odor signal in use.
  • cyclodextrin inclusion complexes of volatile perfumes with a particle size of less than about 12 microns.
  • perfumes and compositions of this invention are the conventional ones known in the art. Selection of any perfume component, or amount of perfume, is based on functional and aesthetic considerations.
  • Preferred perfume components useful in the present invention are the highly volatile, and the moderately volatile perfume ingredients, more preferably the highly volatile, low boiling perfumes.
  • the highly volatile, low boiling, perfume ingredients typically have boiling points of about 260°C or lower, preferably below about 250°C. These highly volatile perfumes are fleeting and are quickly lost as they are released. Many of the more moderately volatile perfume ingredients are also quickly lost.
  • the moderately volatile perfume ingredients are those having boiling points of from about 250°C to about 300°C. Many of the perfume ingredients as discussed hereinafter, along with their odor characters, and their physical and chemical properties, such as boiling point and molecular weight, are given in "Perfume and Flavor Chemicals (Aroma Chemicals),” Steffen Arctander, published by the author, 1969, incorporated herein by reference.
  • Nonlimiting examples of preferred volatile perfume ingredients are allo-ocimene, allyl caproate, allyl heptoate, amyl acetate, amyl propionate, anethole, anisic aldehyde, anisole, benzaldehyde, benzyl acetate, benzyl acetone, benzyl alcohol, benzyl butyrate, benzyl formate, benzyl iso valerate, benzyl propionate, beta gamma hexenol, camphene, carvacrol, laevo-carveol, d-carvone, laevo-carvone, cinnamyl formate, cis-3-hexenyl tiglate, cis-jasmone, cis-3-hexenyl acetate, citral, citronellal, citronellol, citronellyl acetate, citronellyl isobutyrate, cit
  • lavandin contains as major components: linalool, linalyl acetate, geraniol and citronellol, and lemon oil and orange terpenes both contain about 95%) d-limonene.
  • moderately volatile perfume ingredients which can be used in perfume compositions of this invention are amyl cinnamic aldehyde, iso-amyl salicylate, diphenyl methane, gamma-n-methyl ionone, isobutyl quinoline, indole, beta- caryophyllene, cedrene, cinnamic alcohol, dimethyl benzyl carbinyl acetate, eugenol, flor acetate, heliotropine, 3-cis-hexenyl salicylate, hexyl salicylate, lilial (para-tertiary-butyl- alpha-methyl hydrocinnamic aldehyde), gamma-methyl ionone, nerolidol, patchouli alcohol, methyl-n-methyl anthranilate, dodecalactone, lilial (p-t-bucinal), phenyl heptanol,
  • the odor detection threshold of an odorous material is the lowest vapor concentration of that material which can be olfactorily detected.
  • the odor detection threshold and some odor detection threshold values are discussed in, e.g., "Standardized Human Olfactory Thresholds", M. Devos et al, IRL Press at Oxford University Press, 1990, and "Compilation of Odor and Taste Threshold Values Data", F. A. Fazzalari, editor, ASTM Data Series DS 48A, American Society for Testing and Materials, 1978, both of said publications being incorporated by reference.
  • perfume ingredients having significantly low detection threshold useful in the absorbent article of the present invention, are selected from the group consisting of coumarin, vanillin, ethyl vanillin, methyl dihydro isojasmonate, isoeugenol, lyral, gamma-undecalactone, gamma-dodecalactone, methyl beta naphthyl ketone, and mixtures thereof.
  • the perfume/cyclodextrin inclusion complexes of this invention are formed in any of the ways known in the art.
  • the complexes are formed either by bringing the perfume and the cyclodextrin together in a suitable solvent, e.g., water, or, preferably, by kneading/slurrying the ingredients together in the presence of a suitable, preferably minimal, amount of solvent, preferably water.
  • a suitable solvent e.g., water
  • the kneading/slurrying method is particularly desirable because it produces smaller complex particles and requires the use of less solvent, eliminating or reducing the need to further reduce particle size and separate excess solvent. Disclosures of complex formation can be found in Atwood, J.L., J.E.D. Davies & D.D.
  • perfume/cyclodextrin complexes have a molar ratio of perfume compound to cyclodextrin of about 1 : 1.
  • the molar ratio can be either higher or lower, depending on the size of the perfume compound and the identity of the cyclodextrin compound.
  • the molar ratio can be determined by forming a saturated solution of the cyclodextrin and adding the perfume to form the complex. In general the complex will precipitate readily. If not, the complex can usually be precipitated by the addition of electrolyte, change of pH, cooling, etc. The complex can then be analyzed to determine the ratio of perfume to cyclodextrin.
  • the actual complexes are determined by the size of the cavity in the cyclodextrin and the size of the perfume molecule.
  • Desirable complexes can be formed using mixtures of cyclodextrins since perfumes are normally mixtures of materials that vary widely in size. It is usually desirable that at least a majority of the material be alpha-, beta-, and/or gamma-cyclodextrin, more preferably beta-cyclodextrin.
  • the content of the perfume in the beta-cyclodextrin complex is typically from about 5% to about 15%), more normally from about 7% to about 12%.
  • Continuous complexation operation usually involves the use of supersaturated solutions, kneading/slurrying method, and/or temperature manipulation, e.g., heating and then either cooling, freeze-drying, etc.
  • the complexes are dried to a dry powder to make the desired composition. In general, the fewest possible process steps are preferred to avoid loss of perfume. (C). Complex Particle Size
  • Complexes of this invention having a particle size of less than about 12 microns, preferably less than about 10 microns, more preferably less than about 8 microns, and even more preferably less than about 5 microns, improve the release, especially the speed of release of the perfume when the complexes are wetted.
  • the particle size is typically between about 0.001 and 10 microns, preferably between about 0.05 and 5 microns. It is highly desirable that at least an effective amount of the perfume be in complexes having the said particle sizes. It is desirable that at least about 75%, preferably at least about 80%), more preferably at least about 90%, and even more preferably at least about 100%, of the complex that is present have the said particle sizes. Methods for determining particle sizes have been given hereinbefore.
  • Cyclodextrin complexes with large particle sizes can be pulverized to obtain the desired smaller particles of less than about 12 microns by using, e.g., a fluid energy mill.
  • fluid energy mills are the Trost Air Impact Pulverizers, sold by Garlock Inc., Plastomer Products, Newtown, Pennsylvania; the Micronizer fluid energy mills sold by Sturtevant, Inc., Boston, Massachusetts; and the Spiral Jet Mill sold by Alpine Division, MicroPul Corporation (Hosokawa Micron International, Inc.), Summit, New Jersey.
  • Effective amounts are typically in the range of from about 0.005 g to about 10 g, preferably from about 0.01 g to about 3 g, more preferably from about 0.02 g to about 1 g per article.
  • D Matrix Perfume Microcapsules
  • Water-soluble cellular matrix perfume microcapsules are solid particles containing perfume stably held in the cells.
  • the water-soluble matrix material comprises mainly polysaccharide and polyhydroxy compounds.
  • the polysaccharides are preferably higher polysaccharides of the non-sweet, colloidally-soluble types, such as natural gums, e.g., gum arabic, starch derivatives, dextrinized and hydrolyzed starches, and the like.
  • the polyhydroxy compounds are preferably alcohols, plant-type sugars, lactones, monoethers, and acetals.
  • the cellular matrix microcapsules useful in the present invention are prepared by, e.g., (1) forming an aqueous phase of the polysaccharide and polyhydroxy compound in proper proportions, with added emulsifier if necessary or desirable; (2) emulsifying the perfumes in the aqueous phase; and (3) removing moisture while the mass is plastic or flowable, e.g., by spray drying droplets of the emulsion.
  • the matrix materials and process details are disclosed in, e.g., U.S. Pat. No. 3,971.852, Brenner et al., issued July 27, 1976, which is incorporated herein by reference.
  • the present invention preferably has minimal non-encapsulated surface perfume, preferably less than about 1%.
  • Moisture-activated perfume microcapsules can be obtained commercially, e.g., as IN-CAPR from Polak's Frutal Works, Inc., Middletown, New York; and as Optilok System® encapsulated perfumes from Encapsulated Technology, Inc., Nyack, New York.
  • Water-soluble matrix perfume microcapsules preferably have size of from about 0.5 micron to about 300 microns, more preferably from about 1 micron to about 200 microns, most preferably from about 2 microns to about 100 microns.
  • Effective amounts are typically in the range of from about 0.001 g to about 5 g, preferably from about 0.005 g to about 1 g, more preferably from about 0.01 g to about 0.5 g, per article.
  • Small particle size cyclodextrin/perfume complexes can be applied to the fluid absorbent articles by uniformly sprinkling, mixing, or distributing the cyclodextrin/perfume complex powder onto the fluid absorbent materials.
  • the body fluid when in use, the body fluid is not normally distributed to the whole fluid absorbent article, e.g., diaper, but usually localized in a portion of the article.
  • modern disposable diapers are designed with a concentration of the fluid absorbent materials at different locations depending on the sex of the wearers.
  • cyclodextrin/perfume complex powder is applied to areas most likely to be wetted by body fluids to avoid waste in the areas which do not normally receive the body fluids.
  • the cyclodextrin/perfume complex particles may shift away from the preferred locations, and move to the areas where they have less chance to be solubilized by the body fluids, and become less effective.
  • the shifting happens both during the manufacturing processes, e.g., folding, and packaging of the articles, and during later steps, e.g., transportation, and unfolding and refolding of the fluid absorbent article in use. Therefore, it is preferred to provide a means to immobilize the cyclodextrin/perfume complex powder on the preferred locations in the fluid absorbent articles.
  • Immobilization can be accomplished by a variety of methods, i.e., hot-melt adhesives, thermoplastic binder fibers, thermoplastic binder particles, or other methods known to those skilled in the art.
  • a preferred method is to use a water-soluble binder to attach the cyclodextrin/perfume complex powder to the fluid absorbent core and/or topsheets.
  • the water-soluble binders are preferably polymeric. They can be low melting polymers such as polyethylene glycols (PEG), poly(ethylene glycol) methyl ethers, or mixtures thereof.
  • PEG polyethylene glycols
  • Preferred low melting water-soluble PEG materials have the general formula RO- (CH2CH2 ⁇ ) n -R wherein each R is a hydrogen radical, a C1-C4 alkyl radical, or mixtures of such radicals, and have an average molecular weight (MW) of from about 600 to about 20,000 (n is from about 13 to about 450).
  • More preferred PEG materials are polyethylene glycols, poly(ethylene glycol) methyl ethers, or mixtures thereof, with MW of from about 1 ,000 to about 9,000 (n from about 20 to about 200), more preferably from about 1,400 to about 4,500 (n from about 30 to about 100).
  • the weight ratio of the cyclodextrin/perfume complex to the PEG material is from about 3:1 to about 1 :5, preferably from about 2: 1 to about 1 :3.
  • a preferred process of attaching cyclodextrin/perfume complex powder involves admixing solid small-particle-sized cyclodextrin/perfume complex powder with a molten hydrophilic PEG material.
  • the molten mixture can be sprayed directly to the dry fluid absorbent materials or topsheets, then letting the droplets solidify on said materials or nonwoven topsheets.
  • Another preferred method is to pulverize the solidified cyclodextrin complex/binder mixture into small particles first.
  • Said particles can then be attached and immobilized to the surface of the fluid absorbent materials or the nonwoven topsheets by distributing the particles on said surface, melting said particles by, e.g., a heat source, and then resolidifying to bind said particles to said surface.
  • the molten mixture can be solidified to room temperature then pulverized at room temperature or cryogenically.
  • the molten mixture can be prilled by, e.g., spray drying, marumarizing, etc., into solid prills.
  • the solid cyclodextrin/perfume complex/PEG material mixture particles preferably have sizes of from about 10 microns to about 1,000 microns, more preferably from about 20 microns to about 600 microns.
  • Another preferred method is to apply the cyclodextrin/perfume complex slurry to the fluid absorbent material and/or nonwoven topsheet.
  • the small particles of the cyclodextrin complex adhere to the absorbent material and are immobilized on said material. This can be done, e.g., by spraying the cyclodextrin/perfume complex slurry onto the already formed and dry absorbent fiber web.
  • a water-soluble polymer such as PEG, polyvinyl alcohols, polyacrylic acids, and polyvinylpyrrolidone
  • PEG polyvinyl alcohols
  • polyacrylic acids polyvinylpyrrolidone
  • PEG polyvinyl alcohols
  • polyacrylic acids polyvinylpyrrolidone
  • PEG polyvinyl alcohols
  • polyacrylic acids polyvinylpyrrolidone
  • Preferred MW of said polymers are from about 1,000 to about 200,000; more preferred are from about 2,000 to about 100,000.
  • Fluid absorbent material can be any material which is generally compressible, conformable, non-irritating to the wearer's skin, and which is capable of absorbing and retaining fluids.
  • the fluid absorbent material can be constructed from any of a variety of materials commonly used in disposable absorbent articles. These materials are described in U.S. Pat. Nos.: 3,905,863, Ayers, issued Sept. 16, 1975; 3,974,025, Ayers, issued Aug. 10, 1976; 4,191,609, Trokhan, issued Mar. 4, 1980; 4,440,597, Wells et al., issued Apr. 3, 1984; 4,529,480, Trokhan, issued July 16, 1985; and 4,637,859, Trokhan, issued Jan. 20, 1987, all of said patents incorporated herein by reference. Examples of suitable absorbent materials include creped cellulose wadding, cotton fluff, and citric acid cross- linked cellulose pulp disclosed in U.S. Pat.
  • a preferred fluid absorbent material is comminuted and airlaid wood pulp fibers commonly referred to as absorbent fluff.
  • An absorbent fluff having a density of from about 0.05 g to about 0.175 g per cm ⁇ is generally acceptable.
  • fluid absorbent gelling materials are the absorbent gelling materials.
  • fluid absorbent gelling materials (sometimes referred to as “AGM” or “super-sorbers”) are broadly used in fluid absorbent articles. In general, such AGM's have been used only for their fluid-absorbing properties. Such materials form hydrogels on contact with water (e.g., with urine, blood, and the like).
  • AGM absorbent gelling material
  • One highly preferred type of hydrogel-forming, absorbent gelling material is based on the hydrolyed polyacids, especially neutralized polyacrylic acid.
  • Hydrogel-forming polymeric materials of this type are those which, upon contact with fluids (i.e., liquids) such as water or body fluids, imbibe such fluids and thereby form hydrogels.
  • fluid absorbent gelling materials will generally comprise substantially water-insoluble, slightly cross-linked, partially neutralized, hydrogel-forming polymer materials prepared from polymerizable, unsaturated, acid-containing monomers.
  • the polymeric component formed from unsaturated, acid-containing monomers may comprise the entire gelling agent or may be grafted onto other types of polymer moieties such as starch or cellulose.
  • the hydrolyzed polyacrylic acid grafted starch materials are of this latter type.
  • the preferred fluid absorbent gelling materials include hydrolyzed polyacrylonitrile grafted starch, hydrolyzed polyacrylate grafted starch, polyacrylates, maleic anhydride- isobutylene copolymers and combinations thereof.
  • Especially preferred fluid absorbent gelling materials are the hydrolyzed polyacrylates and hydrolyzed polyacrylate grafted starch.
  • cross-linking serves to render these preferred hydrogel-forming absorbent materials substantially water-insoluble, and cross-linking also in part determines the gel volume and extractable polymer characteristics of the hydrogels formed therefrom.
  • Suitable cross-linking agents are well known in the art and include, for example: (1) compounds having at least two polymerizable double bonds; (2) compounds having at least one polymerizable double bond and at least one functional group reactive with the acid-containing monomer material; (3) compounds having at least two functional groups reactive with the acid- containing monomer material; and (4) polyvalent metal compounds which can form ionic cross-linkages.
  • cross-linking agents of the foregoing types are described in greater detail in U.S. Pat. No. 4,076,663, Masuda et al., issued Feb. 28, 1978.
  • Preferred cross-linking agents are the di- or polyesters of unsaturated mono- or polycarboxylic acids with polyols, the bisacrylamides and the di- or triallyl amines.
  • Especially preferred cross- linking agents are N,N'-methylenebisacrylamide, trimethylol propane triacrylate and triallyl amine.
  • the cross-linking agent will generally comprise from about 0.001 mole percent to about 5 mole percent of the preferred materials. More preferably, the cross- linking agent will comprise from about 0.01 mole percent to about 3 mole percent of the absorbent gelling materials used herein.
  • the preferred, slightly cross-linked, hydrogel-forming absorbent gelling materials will generally be employed in their partially neutralized form.
  • such materials are considered partially neutralized when at least about 25 mole percent, preferably at least about 50 mole percent, and more preferably at least about 75 mole percent, of monomers used to form the polymer are acid group-containing monomers which have been neutralized with a salt-forming cation.
  • Suitable salt-forming cations include alkali metal, ammonium, substituted ammonium and amines. This percentage of the total monomers utilized which are neutralized acid group-containing monomers is referred to as the "degree of neutralization.”
  • commercial fluid absorbent gelling materials have a degree of neutralization somewhat less than about 90%.
  • the preferred fluid absorbent gelling materials used herein are those which have a relatively high capacity for imbibing fluids encountered in the fluid absorbent articles; this capacity can be quantified by referencing the "gel volume" of said fluid absorbent gelling materials.
  • Gel volume can be defined in terms of the amount of synthetic urine absorbed by any given fluid absorbent gelling agent buffer and is specified as grams of synthetic urine per gram of gelling agent.
  • Gel volume in synthetic urine can be determined by forming a suspension of about 0.1-0.2 parts of dried fluid absorbent gelling material to be tested with about 20 parts of synthetic urine. This suspension is maintained at ambient temperature under gentle stirring for about 1 hour so that swelling equilibrium is attained. The gel volume (grams of synthetic urine per gram of fluid absorbent gelling material) is then calculated from the weight fraction of the gelling agent in the suspension and the ratio of the liquid volume excluded from the formed hydrogel to the total volume of the suspension.
  • the preferred fluid absorbent gelling materials useful in this invention will have a gel volume of from about 20 to 70 grams, more preferably from about 30 to 60 grams, of synthetic urine per gram of absorbent gelling material.
  • Extractable polymer levels can be determined by: (1) contacting a sample of preferred fluid absorbent gelling material with a synthetic urine solution for a substantial period of time (e.g., at least 16 hours) to reach extraction equilibrium; (2) filtering the formed hydrogel from the supernatant liquid; and (3) determining the polymer content of the filtrate.
  • the particular procedure used to determine extractable polymer content of the preferred fluid absorbent gelling agent buffers herein is set forth in U.S. Pat. No. 4,654,039, Brandt, Goldman and Inglin, issued Mar. 31, 1987, Reissue No. 32,649.
  • the fluid absorbent gelling materials which are especially useful in the fluid absorbent articles herein are those which have an equilibrium extractables content in synthetic urine of no more than about 17%, preferably no more than about 10% by weight of the fluid absorbent gelling material.
  • fluid absorbent gelling materials hereinbefore described are typically used in the form of discrete particles.
  • Such fluid absorbent gelling materials can be of any desired shape, e.g., spherical or semi-spherical, cubic, rod-like polyhedral, etc. Shapes having a large greatest dimension/smallest dimension ratio, like needles and flakes, are also contemplated for use herein. Agglomerates of fluid absorbent gelling material particles may also be used.
  • the size of the fluid absorbent gelling material particles may vary over a wide range. For reasons of industrial hygiene, average particle sizes smaller than about 30 microns are less desirable. Particles having a smallest dimension larger than about 2 mm may also cause a feeling of grittiness in the absorbent article, which is undesirable from a consumer aesthetics standpoint. Furthermore, rate of fluid absorption can be affected by particle size. Larger particles have very much reduced rates of absorption. Fluid absorbent gelling material particles preferably have a particle size of from about 30 microns to about 2 mm for substantially all of the particles. "Particle Size" as used herein means the weighted average of the smallest dimension of the individual particles.
  • fluid absorbent gelling material particles used in fluid absorbent cores will depend upon the degree of fluid absorbent capacity desired, and will generally comprise from about 2% to about 50%> by weight of the fluid absorbent core, more typically from about 5% to about 20% by weight of the fluid absorbent core.
  • such cores can be prepared by any process or technique which provides a web comprising a combination of the fibers and the gelling material particles.
  • web cores can be formed by air-laying a substantially dry mixture of hydrophilic fibers and fluid absorbent gelling material particles and, if desired or necessary, by densifying the resulting web.
  • Such a procedure is described more fully in U.S. Pat. No. 4,610,678, Weisman and Goldman, issued Sept. 9, 1986.
  • the air-laid webs formed by such a procedure will preferably comprise substantially unbonded fibers and will preferably have a moisture content of about 10% or less.
  • tissue laminate Another example combining the fibers and the gelling material particles is a tissue laminate.
  • a fluid absorbent core is described more fully in U.S. Pat. Nos: 4,950,264, Osborn, issued Aug. 21, 1990; 5,009,653, Osborn, issued Apr. 23, 1991; WO 93/01785, Osborn et al., published Feb. 4, 1993, “Stretchable Absorbent Articles;” and WO 93/01781, Johnson et al., published Feb. 4, 1993, “Curving Shaped Absorbent Articles,” all of said patents incorporated herein by reference. As indicated in these references, glue is applied to an air-laid, latex-bonded tissue and absorbent gelling material is added and then the tissue is folded over.
  • the density of the fluid absorbent cores which comprise webs of hydrophilic fibers and fluid absorbent gelling material particles can be of importance in determining the fluid absorbent properties of the cores and of the fluid absorbent articles in which such cores are employed.
  • the density of such fluid absorbent cores herein will preferably be in the range of from about 0.06 to about 0.3 g/crn ⁇ , and more preferably within the range of from about 0.09 to about 0.22 g/cn
  • the basis weight of the fluid absorbent cores herein can range from about 0.02 to 0.12 g/cm ⁇ .
  • Density values for cores of this type can be calculated from basis weight and caliper. Caliper is measured under a confining pressure of 0.137 psi (0.94 kPa). Density and basis weight values include the weight of the fluid absorbent gelling materials and the odor-control material. Density of the cores herein need not be uniform throughout the core. Within the density ranges set forth above, the cores can contain regions or zones of relatively higher or relatively lower density.
  • the finished articles herein will typically be provided with a fluid-receiving facing material.
  • the front-face (“topsheet”) material used herein can be any compliant, soft- feeling, non-irritating (to the wearer's skin) planar material. It functions to contact the wearer's skin, to receive fluid discharges, to allow the discharges to pass readily therethrough into the absorbent element, and to isolate the wearer's skin from the fluids in the absorbent element.
  • the topsheet can be porous paper made from natural or synthetic fibers or mixtures thereof, non-woven fabric made from natural or synthetic fibers or mixtures thereof, apertured plastic film, porous foam, or the like.
  • a preferred topsheet is spun bonded non-woven polyester fabric made from fibers of from about 2.2 to about 2.5 denier, having a basis weight of about 17 g per square meter (m ⁇ ).
  • Another preferred topsheet material has a basis weight of 22 g per m ⁇ and comprises about 65% by weight staple length, 1.5 denier polyester fibers (such as Kodel type 411 polyester fibers as sold by Tennessee Eastman Corporation, Kingsport, Tennessee); about 15% crimped, staple length 1.5 denier rayon fibers; and about 20% acrylic copolymer binder (such as Celanese CPE 8335 as sold by Celanese Corporation, Charlotte. North Carolina).
  • staple length refers to fibers having a length of at least about 15 mm.
  • Still another preferred topsheet is constructed from polypropylene fibers which have been carded and thermally bonded in a spaced-apart pattern. Fibers about 3.8 cm long and of from about 1.5 to about 3.0 denier are suitable. A preferred topsheet of this type has a basis weight of about 24 g per m ⁇ .
  • Suitable topsheets can also be constructed from apertured plastic films such as those described in U.S. Pat. Nos.: 4,342,314, Radel and Thompson, issued Aug. 3, 1982; 4,341,217, Ferguson and Landrigan, issued July 27, 1982; 4,324,246, Mullane and Smith, issued April 13, 1982; and 3,929,135, Thompson, issued Dec. 30, 1975, all of these patents being incorporated herein by reference.
  • thermoplastic material such as 0.0038 cm thick ' polyethylene film is heated above its softening point.
  • the softening point is the temperature at which the thermoplastic material can be formed or molded and is less than the melting point of the material.
  • the heated thermoplastic material in sheet form is then brought into contact with a heated forming screen.
  • the forming screen is preferably an apertured wire mesh screen having the desired aperture size, pattern and configuration.
  • a vacuum is used to draw the heated film against the forming screen, thereby forming the film into the desired pattern and having the desired hole sizes. While the vacuum is still being applied to the film, a jet of hot air is passed over the film. The hot air jet perforates the film in a pattern corresponding to the pattern and size of apertures in the forming screen.
  • Fluid-permeable sheets prepared in the manner of U.S. Pat. No. 4,324,246, supra, are conveniently referred to as "formed films.”
  • the caliper of such films is important since, if the caliper is too great, liquid may accumulate in the apertures and not readily pass therethrough.
  • the sheets typically have a caliper of less than about 0.075 cm, or preferably less than about 0.064 cm.
  • Another formed-film sheet material useful herein is the resilient, 3 -dimensional web exhibiting a fiber-like appearance and tactile impression, comprising a fluid- impervious plastic material, with said web having a multiplicity of apertures, the apertures being defined by a multiplicity of intersecting fiber-like elements, all as disclosed in U.S. Pat. No. 4,342,314, supra.
  • the Radel and Thompson sheet materials can be prepared using hydrophobic plastics such as polyethylene, polypropylene, PVC, and the like, and are well-known for use in fluid absorbent products such as catamenials, and the like. Yet another type of sheet material useful herein is described in U.S. Pat. No.
  • tapered capillaries are in the form of a frustrum of a conical surface, but it is to be understood that any generally tapered structure, such as a frustrum of a pyramid or the like with a triangular, square, or polygonal base, is within the term "tapered capillary"; circular tapered capillaries, however, are used in this description for convenience.
  • the tapered capillaries can be asymmetric (i.e., the angle of taper on one side can be different from that on another side) and that the angle of taper can change continuously (i.e., be curved) over the distance from base to apex.
  • the angle of taper is defined as the angle of the tangent to the side of the capillary at its point of minimum apex opening dimension.
  • the angle of taper suitable for use in topsheets according to the practice of this invention is from about 10° to about 60°.
  • Base opening dimension of the capillaries is defined as the maximum open measurement in the plane of topsheet at said tapered capillary.
  • Apex opening dimension is defined as the maximum open measurement in the apex of said tapered capillary, which apex is remote from the plane of the topsheet.
  • the base and apex opening dimensions are, respectively, the base diameter and the apex diameter.
  • Base diameter and apex diameter are hereinafter used interchangeably with, respectively, base opening dimension and apex opening dimension.
  • the tapered capillary apex diameter is a diameter which will allow liquid to readily pass from the surface of the topsheet to the underlying fluid absorbent core.
  • the apex diameter is from about 0.004 to about 0.100 inch (0.010 to 0.254 centimeter), preferably from about 0.005 to about 0.020 inch (0.013 to 0.051 centimeter).
  • the tapered capillary base diameter is selected to satisfy two criteria.
  • the first of these is the subjective feel of the surface of the topsheet which contacts the skin of the user. It has been discovered that polyethylene can be made to exhibit pleasing, clothlike, non-waxy attributes when the base diameter is within the range from about 0.006 to about 0.250 inch (0.015 to 0.635 centimeter). Preferably, the base diameter should be within the range of from about 0.030 to about 0.060 inch (0.076 to 0.152 centimeter).
  • the second criterion is that the capillary base diameter be small enough to allow an expected liquid droplet to bridge across at least one capillary. This criterion is satisfied by the above dimensions for disposable diapers and sanitary items.
  • the height of the tapered capillary is defined as the distance between the outermost surface of the topsheet (i.e., that surface which normally contacts the skin of the user) and the apex of the tapered capillary. This height, of course, depends upon apex diameter, base diameter, and angle of taper which have been selected as hereinbefore described.
  • the height of the tapered capillary should provide a structure with a minimum tendency to collapse in use. The characteristics of the material of construction of the topsheet in large measure determine suitable ranges for the height.
  • the height of the tapered capillary can be from about 0.003 to about 0.159 inch (0.008 to 0.404 centimeter).
  • a state of relative dryness on the surface of the topsheet implies that most of the liquid which contacts the topsheet is transferred through it to the fluid absorbent element. This in turn implies that each isolated droplet of fluid in contact with the topsheet must be in contact with the base diameter of a tapered capillary.
  • This state of affairs can best be achieved if the land area (the area of the topsheet that exists between the bases of the tapered capillaries) is maintained at a minimum.
  • the minimum limiting value is the case where conical tapered capillaries or pyramidal tapered capillaries are provided in close packed array (where the periphery of the base of each capillary is in contact on all sides with the periphery of the base of adjacent capillaries).
  • the preferred arrangement of minimum land area tends to insure that an individual droplet will contact at least one tapered capillary.
  • a preferred arrangement in disposable diapers is where the tapered capillaries as hereinbefore described are in ordered arrangement with from about 30 to about 1500 tapered capillaries per square inch of topsheet (5 to 231 per square centimeter).
  • the sheets provided by U.S. Pat. No. 4,463,045, supra are designed not only to provide a desirable cloth-like tactile impression, but also to substantially eliminate surface gloss.
  • sheets made of plastic do not have an undesirably shiny, "plasticky” appearance.
  • sheet or film materials used in the practice of this invention are substantially different from fibrous nonwoven materials, which are characterized by a large number of fibers which overlap each other throughout the thickness of the material.
  • sheet materials are made from materials (preferably, hydrophobic thermoplastic polymeric materials) which provide a clean-appearing, stain-resistant or “non-staining" surface, in use.
  • topsheet materials which can be used herein include, for example, various nonabsorbent fibrous or filamentous network sheets which are aqueous-fluid-permeable by virtue of a multiplicity of holes or channels passing therethrough.
  • sheet materials can be prepared by methods well-described in the patent literature. For example, according to the process of U.S. Pat. No. 4,636,419, Madsen et al., issued Jan. 13, 1987, sheets comprising a network of ribboned filaments of two dissimilar chemical types, and with two dissimilar melting or softening points, are contacted and cooled to allow the formation of a network sheet characterized by said different transverse and longitudinal polymer materials. Such sheets can be used in the practice of this invention.
  • Another sheet material useful herein is the formaminous net comprising a reticular network of polymeric filaments, said net comprising two arrays of filaments oriented at a displacement angle of about 20-90 degrees.
  • the aforesaid sheet materials can be prepared using hydrophobic plastics such as polyethylene, polypropylene, PVC, and the like, and are well-known for use in absorbent products such as catamenials, and the like.
  • Such sheet materials typically have a basis weight of about 0.5-5.0 ounces/yd ⁇ (about 0.0016 g/cm ⁇ - 0.016 g/cm ⁇ ), a caliper of 5-25 mils, an open area of about 30-80% and a mesh of 20-40.
  • topsheet is dictated by the product design and the size of the wearer. It can be ascertained by those skilled in the art.
  • the backing sheet (or backsheet) is to prevent body fluids from escaping from, e.g., disposable diaper or catamenial products, and soiling the wearer's outer garments and other surfaces in contact with said products.
  • Any compliant, non-irritating, planar material which is impermeable to body fluids can be used as backsheet. Suitable materials are described with particularity in the hereinbefore incorporated patents and patent application.
  • a preferred backsheet is formed from polyethylene film having a thickness of from about 0.001 to about 0.5 mm, preferably from about 0.012 to about 0.051 mm.
  • Flushable or biodegradable backing sheets can also be used, e.g., with pantiliner devices herein.
  • the size of the backsheet is dictated by the exact product design selected and the size of the intended wearer; it can be readily ascertained by those skilled in the art.
  • the fluid absorbent structures herein can optionally, but preferably, be provided with means to hold them in place on or near the user's body to allow the structures to perform their intended function.
  • diapers and incontinence garments can be provided with well-known commercially-available tape fasteners.
  • Sanitary napkins can be provided with glue stripes facing outward on their backsheet in well-known fashion.
  • Various pins, clips and fasteners of well-known types can optionally be employed.
  • the retaining means also provide an additional benefit in that they can contain the body fluids in a more enclosed space. As a consequence, the malodor is also contained and more readily absorbed and removed by the odor absorbing materials.
  • a perfume used in the following examples is as follows:
  • a mobile slurry is prepared by mixing about 1 kg of beta-cyclodextrin and about 1 ,000 ml of water in a stainless steel mixing bowl of a KitchenAid mixer using a plastic coated heavy-duty mixing blade. Mixing is continued while about 175 g of the perfume is slowly added. The liquid-like slurry immediately starts to thicken and becomes a creamy paste. Stirring is continued for about 30 minutes. The paste is now dough-like in appearance. About 500 ml of water is added to the paste and blended well. Stirring is then resumed for about an additional 30 minutes. During this time the complex again thickens, although not to the same degree as before the additional water is added. The resulting creamy complex is spread in a thin layer on a tray and allowed to air dry. This produces about 1100 g of granular solid which is ground to a fine power. The complex retains some free perfume and still has a residual perfume odor.
  • Complex 2
  • a mobile slurry is prepared by mixing about 600 g of beta-cyclodextrin and 600 ml of water in a stainless steel mixing bowl of a Kitchen Aid® mixer using a plastic coated heavy duty mixing blade. Mixing is continued while about 105 g of the perfume is slowly added. The liquid-like slurry immediately starts to thicken and becomes a creamy paste. Stirring is continued for about 30 minutes. About 1,200 ml of water is slowly added to the slurry with stirring. The stirring continues for about an additional 30 minutes to give a liquid Slurry 1.
  • Slurry 2
  • a mobile slurry is prepared similarly to that of Slurry 1 , except that the additional 1 ,200 ml of water contains about 20 g of dissolved polyethylene glycol with molecular weight of about 3,400.
  • Solid cyclodextrin/perfume complex/polyethylene glycol particles are prepared as follows. One part of Complex 1 is mixed thoroughly with about 1 part of molten polyethylene glycol with an average MW of about 3,400, at about 70o. The composition solidifies upon cooling, and is cryogenically ground with dry ice. The resulting solid cyclodextrin/perfume complex/polyethylene glycol particles are sorted to get particle size of less than about 500 microns.
  • Complex Particles 2
  • Solid cyclodextrin/perfume complex/polyethylene glycol particles are prepared as follows. One part of Complex 1 is mixed thoroughly with about 3 parts of molten polyethylene glycol with an average MW of about 1 ,450, at about 80o. The molten composition is atomized in a spray drying tower to obtain solid particles. Solid particles solidify on the wall of the tower and are removed for particle size classification. Particles larger than about 500 microns are ground further to reduce the particle size by cryogenic grinding with dry ice. Matrix Perfume Microcapsules
  • Water-activated matrix perfume microcapsules can be applied to the fluid absorbent articles by uniformly sprinkling, mixing, or distributing the microcapsules onto the fluid absorbent materials. It is preferred to have the perfume microcapsules applied to areas most likely to be wetted by body fluids.
  • Water-activated matrix perfume microcapsules is an IN-CAP microcapsule sample (hereinafter called "Microcapsule 1") obtainable from Polak's Frutal Works, Inc., having about 50% perfume loading and particle size range of from about 3 microns to about 100 microns.
  • Major components of the perfume are highly volatile components, such as citral and d-limonene.
  • composition of matter suitable for use as an absorbent pad in diapers, sanitary napkins, and the like comprises a substantially homogeneous blend of the following. Ingredient Wt.%
  • composition of matter suitable for use as an absorbent pad in diapers, sanitary napkins, and the like comprises a substantially homogeneous blend of the following: Ingredient Wt.%
  • a pad suitable for use as an absorbent structure in diapers, sanitary napkins, and the like is prepared as follows. Twenty parts of beta-cyclodextrin and 1 part of ZnCl2 are dissolved in about 200 parts of distilled water at about 70°C into a clear solution. This solution is sprayed on about 200 parts of Kraft cellulose fibers and allowed to dry. The resulting pad contains small particles of cyclodextrin which are attached to the cellulose fibers.
  • a pad suitable for use as an absorbent structure in diapers, sanitary napkins, and the like is prepared as follows. About 1 part of beta-cyclodextrin and about 4 parts of polyethylene glycol of average molecular weight (MW) of about 3,400 are dissolved in about 240 parts of distilled water at about 70°C into a clear solution. This solution is sprayed on about 200 parts of Kraft cellulose fibers. The water is then removed by freeze drying. The resulting pad contains small particles of cyclodextrin which are attached to the cellulose fibers.
  • MW average molecular weight
  • a composition of matter suitable for use as an absorbent pad in diapers, sanitary napkins, and the like is prepared as follows. About 1 part of aqueous ZnCb solution (50% solids) is sprayed uniformly on about 60 parts of Kraft cellulose fibers and allowed to dry. About 18 parts of solid beta-cyclodextrin/polyethylene glycol Particles 1 are dry mixed with the cellulose fibers. The resulting mixture is placed in an 80°C oven for about 5 minutes to attach the solid particles to the cellulose fibers.
  • a composition of matter suitable for use as fluid and odor absorbent materials in diapers, sanitary napkins, and the like is prepared as follows. About 1 part of aqueous ZnCl2 solution (50% solids) and about 50 parts of Mixed Perfume Complex/Cyclodextrin Slurry 1 are sprayed uniformly on about 100 parts of an acrylic acid grafted starch hydrogel having an average particle size of about 250 microns ("Sanwet IM 1000" from Sanyo Co., Ltd. Japan). The resulting mixture is placed in an 80°C oven to dry. The mixture is cooled and comminuted, if needed, to produce the absorbent materials.
  • a lightweight pantiliner suitable for use between menstrual periods, and which can be disposed of in a toilet comprises a pad (surface area about 117 cm 2 ); with about 4 g of the composition of Example 2, said pad being interposed between the topsheet of U.S. Pat. No. 4,463,045, supra, and a fibrous, nonwoven, flushable backsheet.
  • a catamenial product in the form of a sanitary napkin having two flaps extending outward from its absorbent core is prepared using the pad of Example 3 (surface area about 117 cm 2 ); per the design of U.S. Pat. No. 4,687,478, Van Tillburg, issued Aug. 18, 1987.
  • the nonglossy sheet of U.S. Pat. No. 4,463,045, supra, is used as the topsheet.
  • a disposable baby diaper using the odor-control pad of Example 4 is prepared as follows. The dimensions listed are for a diaper intended for use with a child in the 6-10 kilogram size range. These dimensions can be modified proportionately for different size children, or for adult incontinence briefs, according to standard practice.
  • Backsheet about 0.025-0.070 mm polyethylene; width at top and bottom about 33 cm; notched inwardly on both sides to a width-at-center of about 28.5 cm; length about 50.2 cm.
  • Topsheet tapered capillary polyethylene topsheet, per U.S. Patent 3,929,135, described hereinabove; width at top and bottom about 33 cm; notched inwardly on both sides to a width-at-center of about 28.5 cm; length about 50.2 cm.
  • Absorbent core air-laid wood pulp fibers per Example 4, about 8.4 mm thick, calendered; width at top and bottom about 28.6 cm; notched inwardly at both sides to a width-at-center of about 10.2 cm; length about 44.5 cm; with about 0.7 g of ZnCb. and about 1.45 g of beta-cyclodextrin dispersed in said core.
  • Elastic leg bands four individual rubber strips (2 per side); width about 4.77 mm; length about 370 mm; thickness about 0.178 mm (all the foregoing dimensions being in the relaxed state).
  • the diaper of Example 9 is prepared in standard fashion by positioning the core- plus-odor control material and scent signal covered with the topsheet on the backsheet and gluing.
  • the elastic bands are stretched to about 50.2 cm and positioned between the topsheet/backsheet along each longitudinal side (2 bands per side) of the core.
  • the inner bands along each side are positioned about 55 mm from the narrowest width of the core (measured from the inner edge of the elastic band). This provides a spacing element along each side of the diaper comprising the flexible topsheet/ backsheet material between the inner elastic and the curved edge of the core.
  • the inner bands are glued down along their length in the stretched state.
  • the outer bands are positioned about 13 mm from the inner bands, and are glued down along their length in the stretched state. Since the topsheet/backsheet assembly is flexible, the glued-down bands contract to elasticize the sides of the diaper.
  • a disposable baby diaper is made similarly to that of Example 9, except that the absorbent core comprises a pad of wood pulp fibers of Example 5.

Abstract

La présente invention se rapporte à des compositions et à des articles tels que des serviettes hygiéniques, des couches, des protège-slips, des vêtements pour adultes incontinents, et des dessous-de-bras, qui minimisent les odeurs liées aux fluides corporels et qui diffusent éventuellement un agréable parfum pour signaler la suppression de l'odeur. La suppression des mauvaises odeurs est mise en oeuvre par une combinaison (1) d'une matière qui inhibe la formation d'odeur et qui possède au moins un attribut sélectionné dans le groupe constitué par une activité antimicrobienne, une activité d'inhibition de l'uréase, une activité d'ajustement du pH et des combinaisons de ces diverses activités; et (2) d'une matière susceptible d'absorber des molécules d'odeurs désagréables, sélectionnée dans le groupe constituée par une cyclodextrine, une zéolite, un carbone activé, le kieselguhr, des matières susceptibles de former des sels acides et des mélanges de ces composés. Le signal parfumé est délivré par des composés d'inclusion cyclodextrine/parfum et/ou des microcapsules parfumées matricielles et il sert à assurer l'utilisateur du bon fonctionnement du produit.
PCT/US1997/022576 1996-12-17 1997-12-09 Articles absorbants dotes d'un systeme de suppression des mauvaises odeurs WO1998026808A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP97952337A EP0946209A2 (fr) 1996-12-17 1997-12-09 Articles absorbants dotes d'un systeme de suppression des mauvaises odeurs
CA002275302A CA2275302A1 (fr) 1996-12-17 1997-12-09 Articles absorbants dotes d'un systeme de suppression des mauvaises odeurs
AU55972/98A AU739247B2 (en) 1996-12-17 1997-12-09 Absorbent articles with odor control system
MX9905739A MX9905739A (es) 1996-12-17 1997-12-09 Articulos absorbentes con sistema de control de olor
KR19997005447A KR20000069529A (ko) 1996-12-17 1997-12-09 냄새 조절 시스템을 갖는 흡수 제품
JP10527792A JP2000505692A (ja) 1996-12-17 1997-12-09 臭気制御システムを有する吸収製品

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3364996P 1996-12-17 1996-12-17
US60/033,649 1996-12-17

Publications (2)

Publication Number Publication Date
WO1998026808A2 true WO1998026808A2 (fr) 1998-06-25
WO1998026808A3 WO1998026808A3 (fr) 1998-08-06

Family

ID=21871627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/022576 WO1998026808A2 (fr) 1996-12-17 1997-12-09 Articles absorbants dotes d'un systeme de suppression des mauvaises odeurs

Country Status (7)

Country Link
EP (1) EP0946209A2 (fr)
JP (1) JP2000505692A (fr)
KR (1) KR20000069529A (fr)
AU (1) AU739247B2 (fr)
CA (1) CA2275302A1 (fr)
MX (1) MX9905739A (fr)
WO (1) WO1998026808A2 (fr)

Cited By (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045973A1 (fr) * 1998-03-12 1999-09-16 The Procter & Gamble Company Article absorbant jetable avec composition de soin de la peau renfermant un inhibiteur enzymatique
WO2000030600A1 (fr) * 1998-11-23 2000-06-02 The Procter & Gamble Company Compositions de desodorisation de la peau
WO2000030599A1 (fr) * 1998-11-23 2000-06-02 The Procter & Gamble Company Compositions de desodorisation et d'assainissement de la peau
WO2000051655A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles comprenant un agent hémolytique et un agent d'oxydation
WO2000051654A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles possedant un systeme de neutralisation d'odeur
WO2000051652A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles absorbants dotes d'un systeme d'elimination des odeurs
WO2000051656A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles absorbants imper-respirants dotes d'un agent d'oxydation
WO2001014043A1 (fr) * 1999-08-17 2001-03-01 Calgon Carbon Corporation Immobilisation d'un biocide sur du charbon actif
WO2001045759A1 (fr) * 1999-12-23 2001-06-28 Kimberly-Clark Worldwide, Inc. Additif encapsule a action retard pour articles absorbants
EP1190725A2 (fr) * 2000-09-25 2002-03-27 Givaudan SA Procédé pour maintenir la perception de parfum en présence d' un matériau absorbant
WO2002094329A1 (fr) * 2001-05-23 2002-11-28 Basf Aktiengesellschaft Articles absorbants contenant un agent desodorisant
JP2002540853A (ja) * 1999-04-06 2002-12-03 エスシーエイ・ハイジーン・プロダクツ・ゼイスト・ベー・ブイ 臭気制御を伴う衛生吸収材
WO2003013622A1 (fr) * 2001-08-07 2003-02-20 Humanscience Technology Co., Ltd Procede de fabrication d'applications sanitaires pour le vagin
WO2003002164A3 (fr) * 2001-06-29 2003-04-17 Dow Global Technologies Inc Polymeres superabsorbants contenant un carboxyle et presentant des proprietes d'elimination des odeurs, et procede de preparation associe
SG96602A1 (en) * 2000-02-23 2003-06-16 Uni Charm Corp Cyclodextrin-containing absorbent article
EP1322343A1 (fr) * 2000-09-29 2003-07-02 Salvona L.L.C. Systeme a composants multiples a liberation controlee pour produits sanitaires en papier
WO2003053487A1 (fr) * 2001-12-20 2003-07-03 Basf Aktiengesellschaft Article absorbant
FR2838295A1 (fr) * 2002-04-15 2003-10-17 Georgia Pacific France Utilisation de sels metalliques du gluconate pour la fabrication de substrats a activite antimicrobienne
WO2003089019A1 (fr) * 2002-04-18 2003-10-30 The Procter & Gamble Company Compositions anti-mauvaises odeurs comprenant des agents de lutte contre les odeurs et des microcapsules contenant une substance active
EP1358894A1 (fr) * 2002-05-03 2003-11-05 SCA Hygiene Products AB Article absorbant avec une structure absorbante pour améliorer les odeurs
EP1380333A1 (fr) * 2002-07-09 2004-01-14 Welland Medical Limited Filtre absorbant les odeurs
US6730819B1 (en) 1999-03-05 2004-05-04 The Procter & Gamble Company Articles comprising oxidizing and hemolytic agents
WO2004108177A1 (fr) * 2003-05-30 2004-12-16 The Procter & Gamble Company Composition et procede permettant de revetir un substrat
WO2006038931A3 (fr) * 2004-09-30 2006-05-04 Kimberly Clark Co Composes quinone reduisant les odeurs
WO2006071318A1 (fr) * 2004-12-23 2006-07-06 Kimberly-Clark Worldwide, Inc. Substrats comportant du charbon actif masqué
AT413988B (de) * 2001-12-20 2006-08-15 Chemiefaser Lenzing Ag Verfahren zur behandlung von cellulosischen formkörpern
WO2007012581A1 (fr) * 2005-07-27 2007-02-01 Basf Se Compositions absorbant l'eau et inhibitrices des odeurs
WO2007053227A1 (fr) * 2005-10-31 2007-05-10 Kimberly-Clark Worldwide, Inc. Articles absorbants presentant une amelioration de la suppression des odeurs
US7234648B2 (en) 2003-10-31 2007-06-26 The Procter And Gamble Company Volatile substance-controlling composition
EP1813291A1 (fr) * 2006-01-20 2007-08-01 Basf Aktiengesellschaft Composition absorbant de l'eau à propriétés désodorisantes contenant des inhibiteurs de l'urease
WO2007106398A2 (fr) * 2006-03-10 2007-09-20 The Procter & Gamble Company Articles absorbants jetables contenant des films anti-odeurs
EP1886698A1 (fr) * 2006-08-09 2008-02-13 The Procter and Gamble Company Articles absorbants dotés d' un système amélioré de suppression des mauvaises odeurs
EP1886700A2 (fr) 2000-05-04 2008-02-13 Kimberly-Clark Worldwide, Inc. Polymères hydrodispersables sensibles aux ions, et procédé pour leur fabrication et éléments les utilisant
WO2008058564A1 (fr) * 2006-11-17 2008-05-22 Sca Hygiene Products Ab Articles absorbants comprenant un sel de zinc organique et un agent antibactérien, ou un chlorure de métal alcalin, ou un chlorure de métal alcalino-terreux
JP2008206997A (ja) * 2008-04-21 2008-09-11 Kao Corp 吸収性物品
US20080294132A1 (en) * 2007-05-23 2008-11-27 Zheng Tan Cellulosic fiber compositions having odor control and methods of making and using the same
WO2009010929A2 (fr) * 2007-07-18 2009-01-22 The Procter & Gamble Company Article absorbant jetable à système anti-odeurs
EP2057258A1 (fr) 2006-08-24 2009-05-13 Basf Se Utilisation de triamides d'acide phosphorique dans des détergents et des applications hygiéniques
EP2056889A1 (fr) 2006-08-24 2009-05-13 Basf Se Utilisation de triamides d'acide phosphorique dans les toilettes
US20090163887A1 (en) * 2007-12-20 2009-06-25 Arehart Kelly D Odor control cellulose granules with quinone compounds
US7635797B2 (en) 2001-10-08 2009-12-22 The Procter & Gamble Company Absorbent articles for feminine protection with gel-forming polysaccharide-comprising wings
US7655829B2 (en) 2005-07-29 2010-02-02 Kimberly-Clark Worldwide, Inc. Absorbent pad with activated carbon ink for odor control
US7666410B2 (en) 2002-12-20 2010-02-23 Kimberly-Clark Worldwide, Inc. Delivery system for functional compounds
US7678367B2 (en) 2003-10-16 2010-03-16 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
CN101772333A (zh) * 2007-08-03 2010-07-07 尤妮佳股份有限公司 一次性尿布
US7754197B2 (en) 2003-10-16 2010-07-13 Kimberly-Clark Worldwide, Inc. Method for reducing odor using coordinated polydentate compounds
US7763061B2 (en) 2004-12-23 2010-07-27 Kimberly-Clark Worldwide, Inc. Thermal coverings
US7772138B2 (en) 2002-05-21 2010-08-10 Kimberly-Clark Worldwide, Inc. Ion sensitive, water-dispersible polymers, a method of making same and items using same
US7794737B2 (en) 2003-10-16 2010-09-14 Kimberly-Clark Worldwide, Inc. Odor absorbing extrudates
US7816285B2 (en) 2004-12-23 2010-10-19 Kimberly-Clark Worldwide, Inc. Patterned application of activated carbon ink
US7837663B2 (en) 2003-10-16 2010-11-23 Kimberly-Clark Worldwide, Inc. Odor controlling article including a visual indicating device for monitoring odor absorption
KR20100126331A (ko) * 2008-02-29 2010-12-01 킴벌리-클라크 월드와이드, 인크. 후각적 젖음 신호를 갖는 흡수 용품
US7879350B2 (en) 2003-10-16 2011-02-01 Kimberly-Clark Worldwide, Inc. Method for reducing odor using colloidal nanoparticles
US7884037B2 (en) 2006-12-15 2011-02-08 Kimberly-Clark Worldwide, Inc. Wet wipe having a stratified wetting composition therein and process for preparing same
US7985209B2 (en) 2005-12-15 2011-07-26 Kimberly-Clark Worldwide, Inc. Wound or surgical dressing
US8066956B2 (en) 2006-12-15 2011-11-29 Kimberly-Clark Worldwide, Inc. Delivery of an odor control agent through the use of a presaturated wipe
US20120157805A1 (en) * 2010-12-21 2012-06-21 Mariangela Caputi Absorbent article having releasable odor control
EP2468309A1 (fr) * 2010-12-21 2012-06-27 The Procter & Gamble Company Article absorbant disposant d'un contrôle amovible des odeurs
EP2468306A1 (fr) * 2010-12-21 2012-06-27 The Procter & Gamble Company Article absorbant comportant un complexe cyclodextrine
US8211369B2 (en) 2003-10-16 2012-07-03 Kimberly-Clark Worldwide, Inc. High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
US8221328B2 (en) 2003-10-16 2012-07-17 Kimberly-Clark Worldwide, Inc. Visual indicating device for bad breath
US8273367B2 (en) 2001-04-17 2012-09-25 The Procter And Gamble Company Articles comprising a mint odor-free cooling agent
WO2012146916A1 (fr) * 2011-04-28 2012-11-01 Gx Labs Holdings Limited Composition désodorisante
WO2012163995A1 (fr) 2011-06-01 2012-12-06 Basf Se Mélanges anti-odeurs destinés à des articles pour incontinence
US8329154B2 (en) 2002-04-18 2012-12-11 The Procter & Gamble Company Compositions comprising a dispersant and microcapsules containing an active material
US8476483B2 (en) 2006-12-13 2013-07-02 Unicharm Corporation Antibacterial sheet and absorbent article
WO2013182469A2 (fr) 2012-06-08 2013-12-12 Basf Se Superabsorbant limitant les odeurs
WO2014019813A1 (fr) 2012-07-30 2014-02-06 Basf Se Mélanges anti-odeurs destinés à des articles pour incontinence
US8748690B2 (en) 2006-11-17 2014-06-10 Sca Hygiene Products Ab Absorbent articles comprising acidic cellulosic fibers and an organic zinc salt
US8791045B2 (en) 2011-11-09 2014-07-29 Kimberly-Clark Worldwide, Inc. Non-tacky wetness indicator composition for application on a polymeric substrate
US8835511B2 (en) 2007-04-04 2014-09-16 The Procter & Gamble Company Absorbent articles including an odor control system
WO2014149994A1 (fr) 2013-03-15 2014-09-25 Georgia-Pacific Consumer Products Lp Substrat formant lingette dispersible dans l'eau
US8871232B2 (en) 2007-12-13 2014-10-28 Kimberly-Clark Worldwide, Inc. Self-indicating wipe for removing bacteria from a surface
WO2014205047A1 (fr) * 2013-06-19 2014-12-24 The Procter & Gamble Company Article absorbant comprenant des composés réactifs complexés ou encapsulés
WO2014205048A1 (fr) * 2013-06-19 2014-12-24 The Procter & Gamble Company Article absorbant comprenant des composés réactifs complexés ou encapsulés
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
WO2015023558A1 (fr) 2013-08-16 2015-02-19 Georgia-Pacific Consumer Products Lp Substrat enchevêtré de fibres libériennes individualisées courtes
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US9119780B2 (en) 2013-10-30 2015-09-01 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of proactive chemistry
US9162085B2 (en) 2011-04-07 2015-10-20 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US9393164B2 (en) 2013-02-28 2016-07-19 Kimberly-Clark Worldwide, Inc. Aldehyde control in personal care products
CN106456411A (zh) * 2014-06-06 2017-02-22 Lb里奥法姆有限公司 可堆肥的吸收性制品
US9585826B2 (en) 2012-11-07 2017-03-07 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of active chemistry
CN106488758A (zh) * 2014-06-30 2017-03-08 尤妮佳股份有限公司 吸收性物品
WO2017223444A1 (fr) * 2016-06-24 2017-12-28 The Procter & Gamble Company Articles absorbants comprenant des agents d'encapsulation
WO2017223439A1 (fr) * 2016-06-24 2017-12-28 The Procter & Gamble Company Article absorbant comprenant des complexes de cyclodextrine
US9889222B2 (en) 2011-11-09 2018-02-13 Kimberly-Clark Worldwide, Inc. Aqueous medium-sensitive coating compositions for triggered release of active ingredients and visual indication for wetness
US9926654B2 (en) 2012-09-05 2018-03-27 Gpcp Ip Holdings Llc Nonwoven fabrics comprised of individualized bast fibers
EP3326659A1 (fr) * 2016-11-23 2018-05-30 Toiletry Sales Limited Articles absorbants comprenant un mélange de contrôle des odeurs
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
CN110325597A (zh) * 2017-03-17 2019-10-11 住友精化株式会社 吸水性树脂组合物、吸收体以及吸收性物品
US10519579B2 (en) 2013-03-15 2019-12-31 Gpcp Ip Holdings Llc Nonwoven fabrics of short individualized bast fibers and products made therefrom
US10640899B2 (en) 2014-05-20 2020-05-05 Gpcp Ip Holdings Llc Bleaching and shive reduction process for non-wood fibers
US10653571B2 (en) 2015-12-10 2020-05-19 The Procter & Gamble Company Article comprising odor control composition
US10722607B2 (en) 2006-08-05 2020-07-28 Givaudan S.A. Perfume compositions
US10844538B2 (en) 2014-05-20 2020-11-24 Gpcp Ip Holdings Llc Bleaching and shive reduction process for non-wood fibers
US11118290B2 (en) 2014-08-07 2021-09-14 Gpcp Ip Holdings Llc Structured, dispersible nonwoven web comprised of hydroentangled individualized bast fibers
US11299591B2 (en) 2018-10-18 2022-04-12 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
WO2022098581A1 (fr) * 2020-11-04 2022-05-12 Van Dyke Richard L Silencieux anti-flatulence et éliminateur d'odeurs
US11466122B2 (en) 2018-10-18 2022-10-11 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11518963B2 (en) 2018-10-18 2022-12-06 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11667776B2 (en) 2018-08-31 2023-06-06 Dow Global Technologies Llc Fiber with odor control component
US11732218B2 (en) 2018-10-18 2023-08-22 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11919678B1 (en) * 2020-06-09 2024-03-05 Keia T. Pile Absorbent storage bag liner

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713414B1 (en) 2000-05-04 2004-03-30 Kimberly-Clark Worldwide, Inc. Ion-sensitive, water-dispersible polymers, a method of making same and items using same
US6835678B2 (en) 2000-05-04 2004-12-28 Kimberly-Clark Worldwide, Inc. Ion sensitive, water-dispersible fabrics, a method of making same and items using same
JP3686851B2 (ja) * 2000-08-23 2005-08-24 株式会社タムラ理研 床擦れ防止装置
KR100467205B1 (ko) * 2001-07-12 2005-01-24 주식회사 엘지생활건강 항균제를 함유하는 일회용 흡수제품
KR100804598B1 (ko) * 2006-07-18 2008-02-20 김공자 원단의 코팅용 야자 활성탄 코팅된 원단의 제조방법
JP5486655B2 (ja) * 2012-09-10 2014-05-07 ユニ・チャーム株式会社 使い捨ておむつ
KR101872445B1 (ko) * 2016-12-06 2018-08-17 주식회사 에치앤디 생리혈 냄새 탈취제, 이를 포함하는 위생재용 탈취패드 및 이를 구비한 위생재
JP7295611B2 (ja) * 2017-03-30 2023-06-21 大王製紙株式会社 吸収性物品及びその製造方法
SE542866C2 (en) * 2018-04-04 2020-07-21 Stora Enso Oyj Method for manufacturing a dry-laid mat for thermoforming

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389023A2 (fr) * 1989-03-20 1990-09-26 The Procter & Gamble Company Structures absorbantes avec moyens de contrôle de l'odeur
WO1994022500A1 (fr) * 1993-03-31 1994-10-13 The Procter & Gamble Company Articles absorbants pour combattre les odeurs, emettant un signal odorant agreable attestant de leur bon fonctionnement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2054095A1 (fr) * 1991-04-22 1992-10-23 Stephanie R. Majors Dispositif de desodorisation a elements multiples
JP3265596B2 (ja) * 1991-11-19 2002-03-11 松下電器産業株式会社 悪臭発生防止部材
US5429628A (en) * 1993-03-31 1995-07-04 The Procter & Gamble Company Articles containing small particle size cyclodextrin for odor control
JPH0819595A (ja) * 1994-07-05 1996-01-23 Maruzen Pharmaceut Co Ltd アンモニア発生防止剤
FR2733154B1 (fr) * 1995-04-18 1997-06-13 Atochem Elf Sa Composition superabsorbante destinee a la realisation d'article d'hygiene du type linges, couches, changes ne developpant pas d'odeurs incommodantes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389023A2 (fr) * 1989-03-20 1990-09-26 The Procter & Gamble Company Structures absorbantes avec moyens de contrôle de l'odeur
WO1994022500A1 (fr) * 1993-03-31 1994-10-13 The Procter & Gamble Company Articles absorbants pour combattre les odeurs, emettant un signal odorant agreable attestant de leur bon fonctionnement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0946209A2 *

Cited By (179)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045973A1 (fr) * 1998-03-12 1999-09-16 The Procter & Gamble Company Article absorbant jetable avec composition de soin de la peau renfermant un inhibiteur enzymatique
WO2000030600A1 (fr) * 1998-11-23 2000-06-02 The Procter & Gamble Company Compositions de desodorisation de la peau
WO2000030599A1 (fr) * 1998-11-23 2000-06-02 The Procter & Gamble Company Compositions de desodorisation et d'assainissement de la peau
US6656456B2 (en) 1998-11-23 2003-12-02 The Procter & Gamble Company Skin deodorizing compositions
WO2000051656A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles absorbants imper-respirants dotes d'un agent d'oxydation
WO2000051652A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles absorbants dotes d'un systeme d'elimination des odeurs
WO2000051654A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles possedant un systeme de neutralisation d'odeur
EP1034800A1 (fr) * 1999-03-05 2000-09-13 The Procter & Gamble Company Articles absorbants comportant un système de contrôle des odeurs contenant un agent oxydant et un agent absorbant
EP1034804A1 (fr) * 1999-03-05 2000-09-13 The Procter & Gamble Company Articles absorbants contenant un agent oxydant et un agent hémolytique
EP1034803A1 (fr) * 1999-03-05 2000-09-13 The Procter & Gamble Company Articles absorbants perméables comportant un système de contrôle des odeurs contenant un agent oxydant
EP1034805A1 (fr) * 1999-03-05 2000-09-13 The Procter & Gamble Company Articles comportant un système de contrôle des odeurs contenant un agent oxydant non-solubles dans l'eau et un agent pour la solubilisation
US6730819B1 (en) 1999-03-05 2004-05-04 The Procter & Gamble Company Articles comprising oxidizing and hemolytic agents
WO2000051655A1 (fr) * 1999-03-05 2000-09-08 The Procter & Gamble Company Articles comprenant un agent hémolytique et un agent d'oxydation
JP2002540853A (ja) * 1999-04-06 2002-12-03 エスシーエイ・ハイジーン・プロダクツ・ゼイスト・ベー・ブイ 臭気制御を伴う衛生吸収材
EP1189642B2 (fr) † 1999-04-06 2010-10-06 SCA Hygiene Products Zeist B.V. Absorbant pour produit d'hygiene avec maitrise des odeurs
WO2001014043A1 (fr) * 1999-08-17 2001-03-01 Calgon Carbon Corporation Immobilisation d'un biocide sur du charbon actif
GB2374806A (en) * 1999-12-23 2002-10-30 Kimberly Clark Co Encapsulated time release additive for absorbent articles
US6653524B2 (en) 1999-12-23 2003-11-25 Kimberly-Clark Worldwide, Inc. Nonwoven materials with time release additives
GB2374806B (en) * 1999-12-23 2004-04-14 Kimberly Clark Co Encapsulated time release additive for absorbent articles
WO2001045759A1 (fr) * 1999-12-23 2001-06-28 Kimberly-Clark Worldwide, Inc. Additif encapsule a action retard pour articles absorbants
SG96602A1 (en) * 2000-02-23 2003-06-16 Uni Charm Corp Cyclodextrin-containing absorbent article
EP1886700A2 (fr) 2000-05-04 2008-02-13 Kimberly-Clark Worldwide, Inc. Polymères hydrodispersables sensibles aux ions, et procédé pour leur fabrication et éléments les utilisant
EP1190725A2 (fr) * 2000-09-25 2002-03-27 Givaudan SA Procédé pour maintenir la perception de parfum en présence d' un matériau absorbant
EP1190725A3 (fr) * 2000-09-25 2003-01-29 Givaudan SA Procédé pour maintenir la perception de parfum en présence d' un matériau absorbant
US6803033B2 (en) 2000-09-25 2004-10-12 Givaudan Sa Process for maintaining fragrance perception in the presence of an absorbent material
EP1322343A1 (fr) * 2000-09-29 2003-07-02 Salvona L.L.C. Systeme a composants multiples a liberation controlee pour produits sanitaires en papier
EP1322343A4 (fr) * 2000-09-29 2006-08-16 Salvona Llc Systeme a composants multiples a liberation controlee pour produits sanitaires en papier
US8273367B2 (en) 2001-04-17 2012-09-25 The Procter And Gamble Company Articles comprising a mint odor-free cooling agent
WO2002094329A1 (fr) * 2001-05-23 2002-11-28 Basf Aktiengesellschaft Articles absorbants contenant un agent desodorisant
WO2003002164A3 (fr) * 2001-06-29 2003-04-17 Dow Global Technologies Inc Polymeres superabsorbants contenant un carboxyle et presentant des proprietes d'elimination des odeurs, et procede de preparation associe
WO2003013622A1 (fr) * 2001-08-07 2003-02-20 Humanscience Technology Co., Ltd Procede de fabrication d'applications sanitaires pour le vagin
US7635797B2 (en) 2001-10-08 2009-12-22 The Procter & Gamble Company Absorbent articles for feminine protection with gel-forming polysaccharide-comprising wings
WO2003053487A1 (fr) * 2001-12-20 2003-07-03 Basf Aktiengesellschaft Article absorbant
AT413988B (de) * 2001-12-20 2006-08-15 Chemiefaser Lenzing Ag Verfahren zur behandlung von cellulosischen formkörpern
WO2003086492A1 (fr) * 2002-04-15 2003-10-23 Georgia-Pacific France Utilisation de sels metalliques du gluconate pour la fabrication de substrats a activite antimicrobienne
FR2838295A1 (fr) * 2002-04-15 2003-10-17 Georgia Pacific France Utilisation de sels metalliques du gluconate pour la fabrication de substrats a activite antimicrobienne
WO2003089019A1 (fr) * 2002-04-18 2003-10-30 The Procter & Gamble Company Compositions anti-mauvaises odeurs comprenant des agents de lutte contre les odeurs et des microcapsules contenant une substance active
US8329154B2 (en) 2002-04-18 2012-12-11 The Procter & Gamble Company Compositions comprising a dispersant and microcapsules containing an active material
EP1358894A1 (fr) * 2002-05-03 2003-11-05 SCA Hygiene Products AB Article absorbant avec une structure absorbante pour améliorer les odeurs
US7772138B2 (en) 2002-05-21 2010-08-10 Kimberly-Clark Worldwide, Inc. Ion sensitive, water-dispersible polymers, a method of making same and items using same
EP1380333A1 (fr) * 2002-07-09 2004-01-14 Welland Medical Limited Filtre absorbant les odeurs
US7666410B2 (en) 2002-12-20 2010-02-23 Kimberly-Clark Worldwide, Inc. Delivery system for functional compounds
US8409618B2 (en) * 2002-12-20 2013-04-02 Kimberly-Clark Worldwide, Inc. Odor-reducing quinone compounds
WO2004108177A1 (fr) * 2003-05-30 2004-12-16 The Procter & Gamble Company Composition et procede permettant de revetir un substrat
CN100356988C (zh) * 2003-05-30 2007-12-26 宝洁公司 涂敷底物的组合物和方法
US8221328B2 (en) 2003-10-16 2012-07-17 Kimberly-Clark Worldwide, Inc. Visual indicating device for bad breath
US7879350B2 (en) 2003-10-16 2011-02-01 Kimberly-Clark Worldwide, Inc. Method for reducing odor using colloidal nanoparticles
US7794737B2 (en) 2003-10-16 2010-09-14 Kimberly-Clark Worldwide, Inc. Odor absorbing extrudates
US7754197B2 (en) 2003-10-16 2010-07-13 Kimberly-Clark Worldwide, Inc. Method for reducing odor using coordinated polydentate compounds
US7678367B2 (en) 2003-10-16 2010-03-16 Kimberly-Clark Worldwide, Inc. Method for reducing odor using metal-modified particles
US8211369B2 (en) 2003-10-16 2012-07-03 Kimberly-Clark Worldwide, Inc. High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
US8702618B2 (en) 2003-10-16 2014-04-22 Kimberly-Clark Worldwide, Inc. Visual indicating device for bad breath
US7837663B2 (en) 2003-10-16 2010-11-23 Kimberly-Clark Worldwide, Inc. Odor controlling article including a visual indicating device for monitoring odor absorption
US7234648B2 (en) 2003-10-31 2007-06-26 The Procter And Gamble Company Volatile substance-controlling composition
WO2006038931A3 (fr) * 2004-09-30 2006-05-04 Kimberly Clark Co Composes quinone reduisant les odeurs
WO2006071318A1 (fr) * 2004-12-23 2006-07-06 Kimberly-Clark Worldwide, Inc. Substrats comportant du charbon actif masqué
US7816285B2 (en) 2004-12-23 2010-10-19 Kimberly-Clark Worldwide, Inc. Patterned application of activated carbon ink
EP2813248A1 (fr) * 2004-12-23 2014-12-17 Kimberly-Clark Worldwide, Inc. Substrats à carbone activé masqué
US7763061B2 (en) 2004-12-23 2010-07-27 Kimberly-Clark Worldwide, Inc. Thermal coverings
AU2005322560B2 (en) * 2004-12-23 2011-07-07 Kimberly-Clark Worldwide, Inc. Masked activated carbon substrates
US8287510B2 (en) 2004-12-23 2012-10-16 Kimberly-Clark Worldwide, Inc. Patterned application of activated carbon ink
US8168852B2 (en) 2004-12-23 2012-05-01 Kimberly-Clark Worldwide, Inc. Activated carbon substrates
WO2007012581A1 (fr) * 2005-07-27 2007-02-01 Basf Se Compositions absorbant l'eau et inhibitrices des odeurs
US7655829B2 (en) 2005-07-29 2010-02-02 Kimberly-Clark Worldwide, Inc. Absorbent pad with activated carbon ink for odor control
US7745685B2 (en) 2005-10-31 2010-06-29 Kimberly-Clark Worldwide, Inc. Absorbent articles with improved odor control
WO2007053227A1 (fr) * 2005-10-31 2007-05-10 Kimberly-Clark Worldwide, Inc. Articles absorbants presentant une amelioration de la suppression des odeurs
AU2006309235B2 (en) * 2005-10-31 2012-04-12 Kimberly-Clark Worldwide, Inc. Absorbent articles with improved odor control
US9012716B2 (en) 2005-10-31 2015-04-21 Kimberly-Clark Worldwide, Inc. Absorbent articles with improved odor control
US7985209B2 (en) 2005-12-15 2011-07-26 Kimberly-Clark Worldwide, Inc. Wound or surgical dressing
WO2007085531A3 (fr) * 2006-01-20 2007-10-11 Basf Ag Compositions absorbant l'eau et inhibitrices des odeurs
EP1813291A1 (fr) * 2006-01-20 2007-08-01 Basf Aktiengesellschaft Composition absorbant de l'eau à propriétés désodorisantes contenant des inhibiteurs de l'urease
US8395012B2 (en) 2006-03-10 2013-03-12 The Procter & Gamble Company Disposable absorbent articles containing odor controlling films
WO2007106398A3 (fr) * 2006-03-10 2007-12-06 Procter & Gamble Articles absorbants jetables contenant des films anti-odeurs
WO2007106398A2 (fr) * 2006-03-10 2007-09-20 The Procter & Gamble Company Articles absorbants jetables contenant des films anti-odeurs
US10722607B2 (en) 2006-08-05 2020-07-28 Givaudan S.A. Perfume compositions
WO2008018044A3 (fr) * 2006-08-09 2008-05-02 Procter & Gamble Articles absorbants incluant un système amélioré de neutralisation des odeurs
WO2008018044A2 (fr) * 2006-08-09 2008-02-14 The Procter & Gamble Company Articles absorbants incluant un système amélioré de neutralisation des odeurs
EP1886698A1 (fr) * 2006-08-09 2008-02-13 The Procter and Gamble Company Articles absorbants dotés d' un système amélioré de suppression des mauvaises odeurs
EP2057258A1 (fr) 2006-08-24 2009-05-13 Basf Se Utilisation de triamides d'acide phosphorique dans des détergents et des applications hygiéniques
EP2056889A1 (fr) 2006-08-24 2009-05-13 Basf Se Utilisation de triamides d'acide phosphorique dans les toilettes
US8748690B2 (en) 2006-11-17 2014-06-10 Sca Hygiene Products Ab Absorbent articles comprising acidic cellulosic fibers and an organic zinc salt
AU2006350910B2 (en) * 2006-11-17 2012-10-11 Essity Hygiene And Health Aktiebolag Absorbent articles comprising an organic zinc salt and an anti-bacterial agent or alkali metal chloride or alkaline earth metal chloride
WO2008058564A1 (fr) * 2006-11-17 2008-05-22 Sca Hygiene Products Ab Articles absorbants comprenant un sel de zinc organique et un agent antibactérien, ou un chlorure de métal alcalin, ou un chlorure de métal alcalino-terreux
US9555150B2 (en) 2006-11-17 2017-01-31 Sca Hygiene Products Ab Absorbent articles comprising an organic zinc salt and an anti-bacterial agent or alkali metal chloride or alkaline earth metal chloride
US8476483B2 (en) 2006-12-13 2013-07-02 Unicharm Corporation Antibacterial sheet and absorbent article
US8066956B2 (en) 2006-12-15 2011-11-29 Kimberly-Clark Worldwide, Inc. Delivery of an odor control agent through the use of a presaturated wipe
US7884037B2 (en) 2006-12-15 2011-02-08 Kimberly-Clark Worldwide, Inc. Wet wipe having a stratified wetting composition therein and process for preparing same
US8835511B2 (en) 2007-04-04 2014-09-16 The Procter & Gamble Company Absorbent articles including an odor control system
US8809616B2 (en) 2007-05-23 2014-08-19 International Paper Company Cellulosic fiber compositions having odor control and methods of making and using the same
US20080294132A1 (en) * 2007-05-23 2008-11-27 Zheng Tan Cellulosic fiber compositions having odor control and methods of making and using the same
EP2671595A1 (fr) 2007-05-23 2013-12-11 International Paper Company Compositions et particules contenant des fibres cellulosiques et des inhibiteurs d'urée stabilisé et/ou activé, ainsi que les procédés de fabrication et d'utilisation de ceux-ci
US20140349835A1 (en) * 2007-05-23 2014-11-27 International Paper Company Compositions and particles containing cellulosic fibers and stabilized-and/or activated-urease inhibitors, as well as methods of making and using the same
WO2008153753A2 (fr) 2007-05-23 2008-12-18 International Paper Company Compositions et particules contenant des fibres cellulosiques et des inhibiteurs stabilisés et/ou activés d'uréase ainsi que leurs procédés de fabrication et d'utilisation
US9370764B2 (en) 2007-05-23 2016-06-21 International Paper Company Compositions and particles containing cellulosic fibers and stabilized-and/or activated-urease inhibitors, as well as methods of making and using the same
WO2009010929A3 (fr) * 2007-07-18 2009-04-30 Procter & Gamble Article absorbant jetable à système anti-odeurs
US8558051B2 (en) 2007-07-18 2013-10-15 The Procter & Gamble Company Disposable absorbent article having odor control system
WO2009010929A2 (fr) * 2007-07-18 2009-01-22 The Procter & Gamble Company Article absorbant jetable à système anti-odeurs
CN101772333B (zh) * 2007-08-03 2013-04-24 尤妮佳股份有限公司 一次性尿布
CN101772333A (zh) * 2007-08-03 2010-07-07 尤妮佳股份有限公司 一次性尿布
US8871232B2 (en) 2007-12-13 2014-10-28 Kimberly-Clark Worldwide, Inc. Self-indicating wipe for removing bacteria from a surface
US20090163887A1 (en) * 2007-12-20 2009-06-25 Arehart Kelly D Odor control cellulose granules with quinone compounds
AU2009219819B2 (en) * 2008-02-29 2013-12-19 Kimberly-Clark Worldwide, Inc. Absorbent article having an olfactory wetness signal
KR20100126331A (ko) * 2008-02-29 2010-12-01 킴벌리-클라크 월드와이드, 인크. 후각적 젖음 신호를 갖는 흡수 용품
KR101596976B1 (ko) 2008-02-29 2016-02-23 킴벌리-클라크 월드와이드, 인크. 후각적 젖음 신호를 갖는 흡수 용품
US8497409B2 (en) * 2008-02-29 2013-07-30 Kimberly-Clark Worldwide, Inc. Absorbent article having an olfactory wetness signal
AU2009219819B9 (en) * 2008-02-29 2014-04-17 Kimberly-Clark Worldwide, Inc. Absorbent article having an olfactory wetness signal
JP2008206997A (ja) * 2008-04-21 2008-09-11 Kao Corp 吸収性物品
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US11096875B2 (en) 2010-04-28 2021-08-24 The Procter & Gamble Company Delivery particle
CN103260656B (zh) * 2010-12-21 2015-01-21 宝洁公司 包含环糊精复合物的吸收制品
CN103260656A (zh) * 2010-12-21 2013-08-21 宝洁公司 包含环糊精复合物的吸收制品
WO2012088231A1 (fr) * 2010-12-21 2012-06-28 The Procter & Gamble Company Article absorbant comprenant un complexe de cyclodextrine
CN103260657A (zh) * 2010-12-21 2013-08-21 宝洁公司 包含环糊精复合物的吸收制品
WO2012087607A1 (fr) * 2010-12-21 2012-06-28 The Procter & Gamble Company Article absorbant ayant un contrôle d'odeur libérable
WO2012087891A1 (fr) * 2010-12-21 2012-06-28 The Procter & Gamble Company Article absorbant comprenant un complexe de cyclodextrine
EP2468308A1 (fr) * 2010-12-21 2012-06-27 The Procter & Gamble Company Article absorbant disposant d'un contrôle amovible des odeurs
EP2468306A1 (fr) * 2010-12-21 2012-06-27 The Procter & Gamble Company Article absorbant comportant un complexe cyclodextrine
EP2468309A1 (fr) * 2010-12-21 2012-06-27 The Procter & Gamble Company Article absorbant disposant d'un contrôle amovible des odeurs
US20120157805A1 (en) * 2010-12-21 2012-06-21 Mariangela Caputi Absorbent article having releasable odor control
CN103260655A (zh) * 2010-12-21 2013-08-21 宝洁公司 具有可释放的气味控制的吸收制品
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US10143632B2 (en) 2011-04-07 2018-12-04 The Procter And Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
US9162085B2 (en) 2011-04-07 2015-10-20 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US9561169B2 (en) 2011-04-07 2017-02-07 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
CN103813769A (zh) * 2011-04-28 2014-05-21 杀菌剂开发有限公司 除臭组合物
WO2012146916A1 (fr) * 2011-04-28 2012-11-01 Gx Labs Holdings Limited Composition désodorisante
WO2012163995A1 (fr) 2011-06-01 2012-12-06 Basf Se Mélanges anti-odeurs destinés à des articles pour incontinence
US9889222B2 (en) 2011-11-09 2018-02-13 Kimberly-Clark Worldwide, Inc. Aqueous medium-sensitive coating compositions for triggered release of active ingredients and visual indication for wetness
US8791045B2 (en) 2011-11-09 2014-07-29 Kimberly-Clark Worldwide, Inc. Non-tacky wetness indicator composition for application on a polymeric substrate
WO2013182469A2 (fr) 2012-06-08 2013-12-12 Basf Se Superabsorbant limitant les odeurs
WO2013182469A3 (fr) * 2012-06-08 2014-02-06 Basf Se Superabsorbant limitant les odeurs
WO2014019813A1 (fr) 2012-07-30 2014-02-06 Basf Se Mélanges anti-odeurs destinés à des articles pour incontinence
US9926654B2 (en) 2012-09-05 2018-03-27 Gpcp Ip Holdings Llc Nonwoven fabrics comprised of individualized bast fibers
US9585826B2 (en) 2012-11-07 2017-03-07 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of active chemistry
US9393164B2 (en) 2013-02-28 2016-07-19 Kimberly-Clark Worldwide, Inc. Aldehyde control in personal care products
US10279071B2 (en) 2013-02-28 2019-05-07 Kimberly-Clark Worldwide, Inc. Aldehyde control in personal care products
US10519579B2 (en) 2013-03-15 2019-12-31 Gpcp Ip Holdings Llc Nonwoven fabrics of short individualized bast fibers and products made therefrom
US9949609B2 (en) 2013-03-15 2018-04-24 Gpcp Ip Holdings Llc Water dispersible wipe substrate
WO2014149994A1 (fr) 2013-03-15 2014-09-25 Georgia-Pacific Consumer Products Lp Substrat formant lingette dispersible dans l'eau
WO2014205047A1 (fr) * 2013-06-19 2014-12-24 The Procter & Gamble Company Article absorbant comprenant des composés réactifs complexés ou encapsulés
US9731042B2 (en) 2013-06-19 2017-08-15 The Procter & Gamble Company Absorbent article comprising complexed or encapsulated reactive compounds
CN105324135A (zh) * 2013-06-19 2016-02-10 宝洁公司 包含复合或包封的活性化合物的吸收制品
WO2014205048A1 (fr) * 2013-06-19 2014-12-24 The Procter & Gamble Company Article absorbant comprenant des composés réactifs complexés ou encapsulés
CN105307692A (zh) * 2013-06-19 2016-02-03 宝洁公司 包含复合或包封的活性化合物的吸收制品
WO2015023558A1 (fr) 2013-08-16 2015-02-19 Georgia-Pacific Consumer Products Lp Substrat enchevêtré de fibres libériennes individualisées courtes
US9119780B2 (en) 2013-10-30 2015-09-01 Kimberly-Clark Worldwide, Inc. Triggerable compositions for two-stage, controlled release of proactive chemistry
US10844538B2 (en) 2014-05-20 2020-11-24 Gpcp Ip Holdings Llc Bleaching and shive reduction process for non-wood fibers
US10640899B2 (en) 2014-05-20 2020-05-05 Gpcp Ip Holdings Llc Bleaching and shive reduction process for non-wood fibers
CN106456411A (zh) * 2014-06-06 2017-02-22 Lb里奥法姆有限公司 可堆肥的吸收性制品
CN106456411B (zh) * 2014-06-06 2019-07-26 Lb里奥法姆有限公司 可堆肥的吸收性制品
CN106488758A (zh) * 2014-06-30 2017-03-08 尤妮佳股份有限公司 吸收性物品
CN106488758B (zh) * 2014-06-30 2020-08-18 尤妮佳股份有限公司 吸收性物品
EP3162335A4 (fr) * 2014-06-30 2017-06-14 Unicharm Corporation Article absorbant
US10675194B2 (en) 2014-06-30 2020-06-09 Unicharm Corporation Absorbent article
US11118290B2 (en) 2014-08-07 2021-09-14 Gpcp Ip Holdings Llc Structured, dispersible nonwoven web comprised of hydroentangled individualized bast fibers
US10653571B2 (en) 2015-12-10 2020-05-19 The Procter & Gamble Company Article comprising odor control composition
US10427133B2 (en) 2016-06-24 2019-10-01 The Procter & Gamble Company Absorbent article comprising cyclodextrin complexes
US11590254B2 (en) 2016-06-24 2023-02-28 The Procter & Gamble Company Absorbent articles comprising encapsulating agents
WO2017223444A1 (fr) * 2016-06-24 2017-12-28 The Procter & Gamble Company Articles absorbants comprenant des agents d'encapsulation
CN109310796B (zh) * 2016-06-24 2021-10-15 宝洁公司 包含环糊精复合物的吸收制品
WO2017223439A1 (fr) * 2016-06-24 2017-12-28 The Procter & Gamble Company Article absorbant comprenant des complexes de cyclodextrine
CN109310796A (zh) * 2016-06-24 2019-02-05 宝洁公司 包含环糊精复合物的吸收制品
WO2017223443A1 (fr) * 2016-06-24 2017-12-28 The Procter & Gamble Company Article absorbant comprenant des complexes de cyclodextrine
US10183273B2 (en) 2016-06-24 2019-01-22 The Procter & Gamble Company Absorbent article comprising cyclodextrin complexes
CN109219453B (zh) * 2016-06-24 2021-07-06 宝洁公司 包含环糊精复合物的吸收制品
CN109219453A (zh) * 2016-06-24 2019-01-15 宝洁公司 包含环糊精复合物的吸收制品
EP3326659A1 (fr) * 2016-11-23 2018-05-30 Toiletry Sales Limited Articles absorbants comprenant un mélange de contrôle des odeurs
EP3597705A4 (fr) * 2017-03-17 2020-11-11 Sumitomo Seika Chemicals Co. Ltd. Composition de résine absorbant l'eau, absorbant et article absorbant
CN110325597A (zh) * 2017-03-17 2019-10-11 住友精化株式会社 吸水性树脂组合物、吸收体以及吸收性物品
US11667776B2 (en) 2018-08-31 2023-06-06 Dow Global Technologies Llc Fiber with odor control component
US11299591B2 (en) 2018-10-18 2022-04-12 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11466122B2 (en) 2018-10-18 2022-10-11 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11518963B2 (en) 2018-10-18 2022-12-06 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11732218B2 (en) 2018-10-18 2023-08-22 Milliken & Company Polyethyleneimine compounds containing N-halamine and derivatives thereof
US11919678B1 (en) * 2020-06-09 2024-03-05 Keia T. Pile Absorbent storage bag liner
WO2022098581A1 (fr) * 2020-11-04 2022-05-12 Van Dyke Richard L Silencieux anti-flatulence et éliminateur d'odeurs
US11918446B2 (en) 2020-11-04 2024-03-05 Richard L. Van Dyke Flatulence silencer and odor eliminator

Also Published As

Publication number Publication date
CA2275302A1 (fr) 1998-06-25
WO1998026808A3 (fr) 1998-08-06
AU739247B2 (en) 2001-10-04
MX9905739A (es) 1999-10-01
KR20000069529A (ko) 2000-11-25
EP0946209A2 (fr) 1999-10-06
JP2000505692A (ja) 2000-05-16
AU5597298A (en) 1998-07-15

Similar Documents

Publication Publication Date Title
AU739247B2 (en) Absorbent articles with odor control system
US5733272A (en) Absorbent articles for odor control with positive scent signal
EP0691856B1 (fr) Articles contenant de petites particules de cyclodextrine pour combattre les odeurs
KR100295532B1 (ko) 방향성미세캡슐접착제를갖는생리대
JP4738699B2 (ja) カチオン性多糖類を包含する臭気抑制系
US20030022573A1 (en) Articles having an odor control system comprising a cationic polysaccharide and an odor controlling agent
US20120226248A1 (en) Absorbent article comprising cyclodextrin complex
CA2297802A1 (fr) Produit de regulation des odeurs a base de cyclodextrine
US10660984B2 (en) Absorbent article comprising a malodor control composition having an acid catalyst
JP4209062B2 (ja) シクロデキストリンを含有した吸収性物品
JP4738700B2 (ja) カチオン性多糖類及びケイ酸塩を包含する吸収製品

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2275302

Country of ref document: CA

Ref country code: CA

Ref document number: 2275302

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 55972/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 09331248

Country of ref document: US

Ref document number: 1019997005447

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/1999/005739

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1997952337

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997952337

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1019997005447

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 55972/98

Country of ref document: AU

WWR Wipo information: refused in national office

Ref document number: 1019997005447

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1997952337

Country of ref document: EP